https://hipa.ai/drug/adagrasib/updates/indication-usage-updated-krazati-label-effective-2026-03-25-2026-03-25 2026-05-11T04:47:58.790Z monthly 0.65 https://hipa.ai/drug/adagrasib/updates/trial-results-posted-nct06024174-2025-07-22 2026-05-12T17:38:20.864Z monthly 0.65 https://hipa.ai/drug/adagrasib/updates/trial-results-posted-nct04418661-2025-04-20 2026-05-12T17:38:22.152Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/boxed-warning-present-label-hadlima-label-effective-2026-05-2026-05-14 2026-06-12T06:23:56.267Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/boxed-warning-present-label-cyltezo-label-effective-2026-03-2026-03-03 2026-05-11T05:00:11.554Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct07147257-2026-01-09 2026-05-12T17:38:18.534Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/boxed-warning-present-label-simlandi-label-effective-2025-12-2025-12-22 2026-05-11T05:45:43.152Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03739853-2025-11-26 2026-05-19T19:43:10.137Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct02632175-2025-10-16 2026-05-19T19:08:02.654Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct04527380-2025-06-05 2026-05-12T18:08:05.466Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/fda-approved-supplemental-application-adalimumab-adbm-2025-05-20 2026-05-11T08:22:37.942Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/fda-approved-supplemental-application-amjevita-adalimumab-2025-05-20 2026-05-11T08:23:05.152Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03828019-2025-05-16 2026-05-12T17:38:21.670Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03906136-2025-04-16 2026-05-12T17:38:22.269Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/phase-3-primary-completion-nct02632175-2025-04-08 2026-05-12T17:38:22.331Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/fda-approved-supplemental-application-amjevita-adalimumab-2025-04-07 2026-05-11T08:54:10.943Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/phase-3-primary-completion-nct06005532-2025-03-31 2026-05-12T17:38:22.630Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03816397-2025-03-26 2026-05-12T17:38:22.718Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/trial-results-posted-nct03505008-2025-03-06 2026-05-12T17:38:23.052Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/ustekinumab-versus-adalimumab-induction-maintenance-therapy-2022-01-01 2026-06-12T16:42:01.776Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/olokizumab-versus-placebo-adalimumab-rheumatoid-arthritis-n-2022-01-01 2026-06-12T16:42:39.718Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/vedolizumab-versus-adalimumab-moderate-severe-ulcerative-2019-01-01 2026-06-12T17:11:58.565Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/efficacy-safety-continuing-versus-withdrawing-adalimumab-2018-01-01 2026-06-12T17:19:37.953Z monthly 0.65 https://hipa.ai/drug/adalimumab/updates/efficacy-safety-adalimumab-every-other-week-versus-2018-01-01 2026-06-12T17:20:44.982Z monthly 0.65 https://hipa.ai/drug/aficamten/updates/trial-results-posted-nct05767346-2026-06-09 2026-06-12T05:59:20.453Z monthly 0.65 https://hipa.ai/drug/aficamten/updates/trial-results-posted-nct05186818-2026-03-03 2026-05-12T17:38:17.977Z monthly 0.65 https://hipa.ai/drug/aficamten/updates/fda-approved-myqorzo-aficamten-nda-219083-2025-12-19 2026-05-11T05:46:42.477Z monthly 0.65 https://hipa.ai/drug/aficamten/updates/phase-3-primary-completion-nct06116968-2025-10-20 2026-05-12T17:38:19.701Z monthly 0.65 https://hipa.ai/drug/aficamten/updates/phase-3-primary-completion-nct05767346-2025-02-28 2026-05-12T18:17:08.157Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/fda-approved-supplemental-application-praluent-alirocumab-2025-10-09 2026-05-11T06:48:33.130Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/phase-3-primary-completion-nct03207945-2025-08-24 2026-05-19T19:19:51.937Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/effect-alirocumab-added-high-intensity-statin-therapy-2022-01-01 2026-06-12T16:42:52.766Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/alirocumab-cardiovascular-outcomes-after-acute-coronary-2018-01-01 2026-06-12T17:21:00.538Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/third-international-consensus-definitions-sepsis-septic-2016-01-01 2026-06-12T17:30:46.377Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/reducing-ldl-pcsk9-inhibitors-clinical-benefit-lipid-drugs-n-2015-01-01 2026-06-12T17:33:23.066Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/efficacy-safety-alirocumab-reducing-lipids-cardiovascular-2015-01-01 2026-06-12T17:34:41.786Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/effects-lowering-ldl-cholesterol-simvastatin-plus-ezetimibe-2011-01-01 2026-06-12T17:37:09.213Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/rosuvastatin-cardiovascular-events-patients-undergoing-2009-01-01 2026-06-12T17:38:10.376Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/atorvastatin-patients-type-2-diabetes-mellitus-undergoing-2005-01-01 2026-06-12T17:39:04.700Z monthly 0.65 https://hipa.ai/drug/alirocumab/updates/human-homologue-drosophila-toll-protein-signals-activation-1997-01-01 2026-06-12T17:39:42.371Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/boxed-warning-present-label-herceptin-hylecta-label-2026-05-29 2026-06-12T06:10:24.596Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/boxed-warning-present-label-phesgo-label-effective-2026-05-2026-05-21 2026-06-12T06:43:11.791Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/trial-results-posted-nct05074940-2026-05-08 2026-05-12T17:38:23.411Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-vyvgart-hytrulo-2026-05-08 2026-06-12T06:30:35.347Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-rybrevant-faspro-amivantamab-hyaluronidase-lpuj-2026-02-13 2026-05-11T05:09:45.542Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/trial-results-posted-nct05388669-2026-02-02 2026-05-12T17:38:18.277Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-darzalex-faspro-2026-01-27 2026-05-11T05:24:13.955Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-rybrevant-faspro-amivantamab-hyaluronidase-lpuj-2025-12-17 2026-05-12T17:55:03.103Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-darzalex-faspro-2025-11-19 2026-05-11T06:14:05.155Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/indication-usage-updated-rybrevant-label-effective-2025-11-2025-11-11 2026-05-11T16:05:20.207Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-darzalex-faspro-2025-11-06 2026-05-11T06:26:02.132Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/trial-results-posted-nct05663866-2025-10-20 2026-05-12T17:38:19.701Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-vyvgart-hytrulo-2025-10-17 2026-05-11T06:39:56.589Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-rybrevant-amivantamab-2025-08-14 2026-05-11T07:25:37.134Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/trial-results-posted-nct04988295-2025-04-16 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-vyvgart-hytrulo-2025-04-10 2026-06-12T06:52:28.438Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-phesgo-pertuzumab-2024-11-22 2026-06-12T16:00:39.757Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-vyvgart-hytrulo-2024-08-08 2026-06-12T16:04:41.150Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-vyvgart-hytrulo-2024-06-21 2026-06-12T16:06:11.442Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-supplemental-application-herceptin-hylecta-2024-06-18 2026-06-12T16:06:31.638Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/phase-3-primary-completion-nct05388669-2024-01-03 2026-06-12T16:14:37.845Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/phase-3-primary-completion-nct04487080-2023-08-11 2026-06-12T16:23:35.637Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/phase-3-primary-completion-nct04988295-2023-07-10 2026-06-12T16:24:50.142Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-vyvgart-hytrulo-efgartigimod-alfa-hyaluronidase-2023-06-20 2026-06-12T16:25:51.438Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/phase-3-primary-completion-nct04538664-2023-05-03 2026-06-12T16:26:21.453Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-phesgo-pertuzumab-trastuzumab-hyaluronidase-2020-06-29 2026-06-12T16:57:06.428Z monthly 0.65 https://hipa.ai/drug/amivantamab/updates/fda-approved-herceptin-hylecta-trastuzumab-hyaluronidase-2019-02-28 2026-06-12T17:09:08.473Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct06267001-2026-06-10 2026-06-12T05:57:13.438Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04513925-2026-06-03 2026-06-12T06:06:33.536Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04619797-2026-06-03 2026-06-12T06:40:01.786Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2026-05-15 2026-06-12T06:46:18.887Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-hybreza-2026-05-15 2026-06-12T06:46:47.731Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03762018-2026-05-14 2026-06-12T06:24:33.588Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04042558-2026-05-12 2026-06-12T06:27:50.637Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03337698-2026-05-12 2026-06-12T06:29:10.085Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04245085-2026-05-12 2026-06-12T06:29:35.432Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04665843-2026-05-05 2026-05-12T17:42:32.816Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03554083-2026-05-04 2026-05-12T17:38:16.628Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04262154-2026-04-24 2026-05-12T17:38:17.348Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05251948-2026-04-15 2026-05-12T17:38:17.587Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct02912559-2026-04-14 2026-05-12T17:38:17.604Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04540211-2026-04-09 2026-05-12T17:38:17.635Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04637594-2026-03-20 2026-05-12T17:38:17.823Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04902040-2026-03-18 2026-05-12T17:38:17.828Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04832854-2026-03-11 2026-05-12T17:38:17.929Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct05468489-2026-02-28 2026-05-12T17:38:17.977Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct02530489-2026-02-17 2026-05-12T17:38:18.121Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05746481-2026-01-22 2026-05-19T22:20:48.185Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04770272-2026-01-12 2026-05-12T17:38:18.519Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/atezolizumab-plus-folfox-stage-iii-mismatch-repair-deficient-2026-01-01 2026-05-12T17:36:03.311Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03199885-2025-12-30 2026-05-12T17:39:00.542Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct04294810-2025-12-30 2026-05-19T20:23:21.592Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct05047250-2025-12-30 2026-05-19T21:17:13.782Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05091567-2025-12-29 2026-05-12T17:39:37.943Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04148911-2025-12-26 2026-05-12T17:40:03.913Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04446117-2025-12-18 2026-05-12T17:38:18.756Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct06267001-2025-12-16 2026-05-12T17:38:18.806Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04862949-2025-12-12 2026-05-12T17:55:28.634Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03755791-2025-12-11 2026-05-19T19:44:31.360Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03836066-2025-12-04 2026-05-12T17:38:18.971Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-hybreza-2025-11-24 2026-05-11T06:10:27.146Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03193190-2025-11-21 2026-05-19T19:19:31.523Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03371017-2025-11-12 2026-05-12T17:38:19.310Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03280563-2025-11-10 2026-05-19T19:21:06.116Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04665856-2025-10-29 2026-05-12T17:38:19.503Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05694013-2025-10-22 2026-05-12T17:38:19.654Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03901573-2025-10-22 2026-05-19T19:52:08.635Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04256421-2025-10-22 2026-05-19T20:18:31.802Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04751929-2025-10-02 2026-05-19T20:55:52.929Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2025-10-02 2026-06-12T15:51:04.629Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-hybreza-2025-10-02 2026-06-12T15:51:28.222Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03456063-2025-10-01 2026-05-12T17:38:19.902Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04487067-2025-09-22 2026-05-12T17:38:19.990Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05459129-2025-09-15 2026-05-12T17:38:20.112Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct04732598-2025-09-12 2026-05-19T20:54:10.766Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03556839-2025-08-31 2026-05-12T17:38:20.321Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03977467-2025-08-27 2026-05-19T19:55:57.036Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05109442-2025-08-20 2026-05-12T17:38:20.507Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04740918-2025-08-08 2026-05-19T20:54:32.512Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05116202-2025-07-18 2026-05-19T21:23:59.708Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04477759-2025-07-15 2026-05-12T17:38:20.968Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03799835-2025-06-30 2026-05-19T19:46:23.160Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct04660344-2025-06-15 2026-05-19T20:50:03.421Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03811002-2025-06-12 2026-05-12T17:38:21.293Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03694262-2025-05-30 2026-05-12T17:38:21.501Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05224141-2025-05-30 2026-05-12T17:38:21.553Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03108131-2025-05-28 2026-05-12T17:38:21.553Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct04513925-2025-05-27 2026-05-12T17:38:21.565Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04941287-2025-05-23 2026-05-12T17:38:21.566Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04642365-2025-05-21 2026-05-12T17:38:21.603Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04732286-2025-05-08 2026-05-12T17:38:21.815Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct05904886-2025-05-08 2026-05-12T17:38:21.819Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04602078-2025-04-24 2026-05-12T17:38:22.081Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03473756-2025-04-09 2026-05-12T17:38:22.331Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03829501-2025-04-02 2026-05-12T17:38:22.604Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04512430-2025-04-02 2026-05-12T17:38:22.604Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05834348-2025-03-30 2026-05-12T17:38:22.685Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct02486718-2025-03-30 2026-05-12T17:38:22.686Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03024437-2025-03-20 2026-05-12T17:38:22.848Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04101357-2025-03-18 2026-05-12T17:38:22.856Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03353831-2025-03-11 2026-05-12T17:38:22.955Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct02839707-2025-03-04 2026-05-12T17:38:23.061Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04322643-2025-02-25 2026-05-12T18:18:27.804Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04300647-2025-02-07 2026-05-12T18:29:21.195Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct02912559-2025-02-04 2026-06-12T06:53:02.826Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/zanzalintinib-plus-atezolizumab-versus-regorafenib-2025-01-01 2026-06-12T06:55:34.233Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/adjuvant-atezolizumab-early-triple-negative-breast-cancer-2025-01-01 2026-06-12T15:52:55.450Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/efficacy-safety-first-line-maintenance-therapy-lurbinectedin-2025-01-01 2026-06-12T15:53:10.424Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/atezolizumab-high-risk-locally-advanced-squamous-cell-2025-01-01 2026-06-12T15:55:11.207Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/ctdna-guided-adjuvant-atezolizumab-muscle-invasive-bladder-2025-01-01 2026-06-12T15:57:31.060Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-tecentriq-hybreza-atezolizumab-hyaluronidase-2024-09-12 2026-06-12T16:03:09.508Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct05091567-2024-07-29 2026-06-12T16:05:35.400Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03199885-2024-04-30 2026-06-12T16:08:19.241Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03811002-2024-04-21 2026-06-12T16:09:29.116Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/atezolizumab-plus-bevacizumab-chemotherapy-metastatic-2024-01-01 2026-06-12T16:15:34.489Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/phase-3-primary-completion-nct03762018-2023-09-01 2026-06-12T16:22:54.403Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/atezolizumab-plus-bevacizumab-versus-active-surveillance-2023-01-01 2026-06-12T16:28:47.347Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/atezolizumab-plus-cabozantinib-versus-cabozantinib-2023-01-01 2026-06-12T16:29:30.350Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/first-line-atezolizumab-monotherapy-versus-single-agent-2023-01-01 2026-06-12T16:30:11.817Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2022-12-09 2026-06-12T16:31:36.017Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2022-12-02 2026-06-12T16:31:48.744Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2021-10-15 2026-06-12T16:44:51.857Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2021-10-06 2026-06-12T16:45:30.056Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2021-04-13 2026-06-12T16:48:59.028Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2021-02-17 2026-06-12T16:50:17.456Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2020-12-18 2026-06-12T16:54:49.821Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2020-09-30 2026-06-12T16:56:06.887Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2020-07-30 2026-06-12T16:56:36.832Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2020-05-29 2026-06-12T16:58:47.826Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2020-05-18 2026-06-12T16:59:15.318Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2019-12-03 2026-06-12T17:05:24.599Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2019-05-06 2026-06-12T17:07:04.756Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2019-03-18 2026-06-12T17:08:04.378Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2019-03-08 2026-06-12T17:08:21.021Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2018-12-06 2026-06-12T17:13:37.334Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2018-07-02 2026-06-12T17:15:54.240Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2018-06-19 2026-06-12T17:16:27.038Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2018-06-14 2026-06-12T17:16:44.840Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2018-04-30 2026-06-12T17:17:30.808Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-supplemental-application-tecentriq-atezolizumab-2017-04-17 2026-06-12T17:25:02.978Z monthly 0.65 https://hipa.ai/drug/atezolizumab/updates/fda-approved-tecentriq-atezolizumab-bla-761034-2016-05-18 2026-06-12T17:29:22.958Z monthly 0.65 https://hipa.ai/drug/batoclimab/updates/phase-3-primary-completion-nct05517447-2026-04-02 2026-05-12T17:38:17.682Z monthly 0.65 https://hipa.ai/drug/batoclimab/updates/phase-3-primary-completion-nct05524571-2026-02-03 2026-05-12T17:51:48.873Z monthly 0.65 https://hipa.ai/drug/batoclimab/updates/phase-3-primary-completion-nct05517421-2025-11-02 2026-05-12T17:38:19.408Z monthly 0.65 https://hipa.ai/drug/batoclimab/updates/phase-3-primary-completion-nct05403541-2025-01-10 2026-06-12T06:55:01.083Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/fda-approved-baxfendy-baxdrostat-nda-219878-2026-05-15 2026-06-12T06:47:03.405Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/effect-baxdrostat-ambulatory-blood-pressure-patients-2026-01-01 2026-05-12T17:37:05.822Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/trial-results-posted-nct06336356-2025-12-17 2026-05-12T17:38:18.797Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/phase-3-primary-completion-nct06344104-2025-11-24 2026-05-19T23:01:37.992Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/phase-3-primary-completion-nct06168409-2025-08-17 2026-05-19T22:54:29.679Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/phase-3-primary-completion-nct06034743-2025-05-21 2026-05-19T22:44:44.875Z monthly 0.65 https://hipa.ai/drug/baxdrostat/updates/efficacy-safety-baxdrostat-uncontrolled-resistant-2025-01-01 2026-06-12T15:56:11.882Z monthly 0.65 https://hipa.ai/drug/bi-3000202/updates/trial-results-posted-nct05945888-2026-06-08 2026-06-12T06:00:32.375Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct04009499-2026-05-26 2026-06-12T06:18:36.844Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct04009499-2026-05-25 2026-06-12T06:19:14.967Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/trial-results-posted-nct04718896-2026-05-18 2026-06-12T06:44:53.948Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/trial-results-posted-nct06011733-2026-02-20 2026-05-12T17:38:18.074Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct06624228-2026-02-06 2026-05-19T23:12:05.701Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/trial-results-posted-nct04255862-2025-04-10 2026-05-12T17:38:22.330Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/trial-results-posted-nct05292131-2025-04-10 2026-05-12T17:38:22.331Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct06011733-2025-02-05 2026-05-12T18:30:42.427Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/efficacy-safety-bimekizumab-patients-moderate-severe-2024-01-01 2026-06-12T16:18:49.345Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/bimekizumab-patients-active-psoriatic-arthritis-previous-2023-01-01 2026-06-12T16:28:33.577Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/bimekizumab-patients-psoriatic-arthritis-naive-biologic-2023-01-01 2026-06-12T16:30:23.819Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct04242446-2022-04-07 2026-06-12T16:35:01.850Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/phase-3-primary-completion-nct04242498-2021-11-09 2026-06-12T16:44:36.865Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/bimekizumab-versus-adalimumab-plaque-psoriasis-n-engl-j-med-2021-01-01 2026-06-12T16:52:22.181Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/bimekizumab-versus-ustekinumab-treatment-moderate-severe-2021-01-01 2026-06-12T16:52:53.626Z monthly 0.65 https://hipa.ai/drug/bimekizumab/updates/bimekizumab-efficacy-safety-moderate-severe-plaque-psoriasis-2021-01-01 2026-06-12T16:54:05.895Z monthly 0.65 https://hipa.ai/drug/botensilimab/updates/trial-results-posted-nct05571293-2026-05-22 2026-06-12T06:20:07.942Z monthly 0.65 https://hipa.ai/drug/brexanolone/updates/trial-results-posted-nct05329779-2026-01-22 2026-05-19T21:40:55.137Z monthly 0.65 https://hipa.ai/drug/buntanetap/updates/trial-results-posted-nct05686044-2025-04-29 2026-05-12T17:38:22.079Z monthly 0.65 https://hipa.ai/drug/buntanetap/updates/trial-results-posted-nct05357989-2025-03-03 2026-05-12T17:38:23.083Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06534411-2026-06-02 2026-06-12T06:08:21.315Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06388187-2026-04-22 2026-05-12T17:43:47.272Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06221969-2026-03-04 2026-05-19T22:57:45.899Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06131437-2025-12-08 2026-05-19T22:52:20.410Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06065540-2025-11-19 2026-05-19T22:46:41.923Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06323174-2025-10-01 2026-05-19T23:00:56.992Z monthly 0.65 https://hipa.ai/drug/cagrisema/updates/phase-3-primary-completion-nct06323161-2025-09-09 2026-05-19T23:00:56.532Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-er-label-2026-06-09 2026-06-12T05:57:53.793Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-06-09 2026-06-12T05:58:39.559Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-06-08 2026-06-12T06:01:57.203Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-27 2026-06-12T06:14:37.686Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-22 2026-06-12T06:19:31.456Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-extended-2026-05-22 2026-06-12T06:41:31.992Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-glyburide-metformin-2026-05-21 2026-06-12T06:42:09.847Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-21 2026-06-12T06:42:40.165Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-05-19 2026-06-12T06:44:10.204Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-18 2026-06-12T06:44:21.713Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-13 2026-06-12T06:24:44.589Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-11 2026-06-12T06:30:12.670Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-08 2026-05-12T17:22:20.544Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-glyburide-metformin-2026-05-07 2026-05-12T17:22:57.473Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-07 2026-05-12T17:23:18.545Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-06 2026-05-12T17:41:58.220Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-05-05 2026-05-11T15:50:35.246Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct02874430-2026-04-22 2026-05-12T17:38:17.470Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-04-16 2026-05-09T18:55:29.937Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct02122185-2026-03-27 2026-05-12T17:38:17.729Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-03-18 2026-05-11T04:51:48.129Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-02-10 2026-05-11T05:13:25.277Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-31 2026-05-12T17:32:33.446Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-29 2026-05-11T05:22:10.514Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct03076281-2026-01-29 2026-05-12T17:38:18.356Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-28 2026-05-11T05:23:22.745Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-14 2026-05-11T05:30:32.800Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct06504862-2026-01-09 2026-05-12T17:38:18.534Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-01 2026-05-11T05:39:03.586Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-01-01-4f203f 2026-05-12T17:01:28.958Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/indication-usage-updated-metformin-hcl-label-effective-2025-2025-12-26 2026-05-11T05:44:06.626Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-12-18 2026-05-11T05:48:42.002Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct03109847-2025-12-11 2026-05-12T17:38:18.895Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/indication-usage-updated-metformin-hcl-label-effective-2025-2025-12-05 2026-05-11T05:59:07.132Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/fda-approved-sitagliptin-metformin-hydrochloride-sitagliptin-2025-12-02 2026-05-11T06:02:40.446Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-12-01 2026-05-11T06:05:20.006Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-10-28 2026-05-11T06:32:06.506Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-10-15 2026-05-11T06:44:20.722Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-glipizide-metformin-2025-10-14 2026-05-11T06:44:49.994Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/indication-usage-updated-metformin-label-effective-2025-08-2025-08-22 2026-05-11T07:21:20.512Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-08-18 2026-05-11T07:24:10.925Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-08-06 2026-05-11T07:30:01.600Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-08-06-d15edf 2026-05-12T17:01:28.890Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/phase-3-primary-completion-nct04221750-2025-07-31 2026-05-12T17:38:20.698Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-06-30 2026-05-11T07:54:49.691Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-06-18 2026-05-11T08:00:30.618Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-zituvimet-label-effective-2025-2025-06-09 2026-05-11T08:07:29.230Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2025-04-23 2026-05-11T08:40:25.747Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/fda-approved-metformin-hydrochloride-oral-solution-metformin-2025-04-14 2026-05-11T08:48:47.435Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct01905046-2025-04-13 2026-05-12T17:38:22.306Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-alogliptin-metformin-2025-04-11 2026-05-11T08:51:18.987Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-extended-2025-03-26 2026-05-11T09:02:31.839Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct02980276-2025-03-17 2026-05-12T17:38:22.906Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/fda-approved-metformin-hydrochloride-metformin-hydrochloride-2025-03-13 2026-05-11T09:14:40.307Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/trial-results-posted-nct03170518-2025-03-12 2026-05-12T17:38:22.955Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/canagliflozin-renal-outcomes-type-2-diabetes-nephropathy-n-2019-01-01 2026-06-12T17:11:11.374Z monthly 0.65 https://hipa.ai/drug/canagliflozin/updates/efficacy-safety-canagliflozin-versus-glimepiride-patients-2013-01-01 2026-06-12T17:36:38.881Z monthly 0.65 https://hipa.ai/drug/cbl-514/updates/trial-results-posted-nct05234736-2026-05-22 2026-06-12T06:21:23.900Z monthly 0.65 https://hipa.ai/drug/crovalimab/updates/phase-3-primary-completion-nct05494619-2026-03-19 2026-05-12T17:38:17.821Z monthly 0.65 https://hipa.ai/drug/crovalimab/updates/trial-results-posted-nct04434092-2025-11-10 2026-05-12T17:38:19.346Z monthly 0.65 https://hipa.ai/drug/crovalimab/updates/phase-3-primary-completion-nct04861259-2025-10-09 2026-05-12T17:38:19.800Z monthly 0.65 https://hipa.ai/drug/crovalimab/updates/phase-3-primary-completion-nct04958265-2025-07-04 2026-05-12T17:38:21.028Z monthly 0.65 https://hipa.ai/drug/crovalimab/updates/phase-3-primary-completion-nct04654468-2022-02-10 2026-06-12T16:36:17.165Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct04965935-2026-06-08 2026-06-12T06:02:13.676Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-05-27 2026-06-12T06:12:22.786Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-05-18 2026-06-12T06:45:11.299Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-05-13 2026-06-12T06:25:01.570Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-05-11 2026-06-12T06:29:54.104Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct05321706-2026-04-30 2026-05-12T17:38:17.144Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-04-08 2026-05-11T04:36:46.327Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06 2026-05-11T04:37:36.856Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-saxagliptin-dapagliflozin-2026-04-06 2026-05-12T17:27:08.743Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06-98daa0 2026-05-12T17:01:29.005Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06-a5a4b9 2026-05-12T17:01:29.074Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06-35dd1d 2026-05-12T17:01:29.127Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211541-2026-04-06 2026-05-11T04:39:10.437Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-04-06 2026-05-11T04:39:25.394Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211545-2026-04-06 2026-05-12T17:27:35.265Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211560-2026-04-06 2026-05-11T04:40:02.863Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06-9aad22 2026-05-12T17:01:29.171Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211482-2026-04-06 2026-05-11T04:40:37.112Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-metformin-hydrochloride-2026-04-06-8a2d8d 2026-05-12T17:01:29.220Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211582-2026-04-06 2026-05-11T04:41:09.899Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211312-2026-04-06 2026-05-11T15:54:06.718Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211468-2026-04-06 2026-05-11T04:41:43.256Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211523-2026-04-06 2026-05-11T04:42:09.421Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211470-2026-04-06 2026-05-11T04:42:23.972Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211156-2026-04-06 2026-05-11T04:42:37.996Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211531-2026-04-06 2026-05-12T17:28:09.156Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211506-2026-04-06 2026-05-11T04:43:10.423Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211535-2026-04-06 2026-05-11T04:43:23.300Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/fda-approved-dapagliflozin-dapagliflozin-anda-211478-2026-04-06 2026-05-11T04:43:37.515Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2026-2026-04-02 2026-05-11T04:44:28.436Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06405178-2026-03-30 2026-06-12T06:48:48.982Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06820567-2026-03-01 2026-05-12T17:38:17.976Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06589765-2026-02-18 2026-05-19T23:11:53.539Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct05139914-2026-02-11 2026-05-19T21:25:44.356Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06711185-2026-01-30 2026-05-19T23:12:56.419Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct06263673-2026-01-28 2026-05-19T22:58:47.255Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct06269484-2026-01-20 2026-05-12T17:38:18.467Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/indication-usage-updated-dapagliflozin-label-effective-2025-2025-10-31 2026-05-11T06:29:12.462Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct03968224-2025-10-15 2026-05-19T19:55:39.303Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct04818034-2025-10-08 2026-05-12T17:38:19.830Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06192108-2025-09-26 2026-05-19T22:55:37.186Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06535529-2025-08-01 2026-05-12T17:38:20.698Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct05468203-2025-07-18 2026-05-12T17:38:20.923Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06415773-2025-06-13 2026-05-12T17:38:21.244Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06421870-2025-05-31 2026-05-12T17:38:21.470Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct05748925-2025-04-16 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct06619600-2025-03-31 2026-05-12T17:38:22.684Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct05957887-2025-03-15 2026-05-12T17:38:22.919Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct04564742-2025-03-07 2026-05-12T17:38:23.012Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/effect-dapagliflozin-metabolic-dysfunction-associated-2025-01-01 2026-06-12T06:55:57.643Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/phase-3-primary-completion-nct04965935-2024-08-30 2026-06-12T16:03:32.667Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/dapagliflozin-critically-ill-patients-acute-organ-2024-01-01 2026-06-12T16:14:49.424Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/acetazolamide-acute-decompensated-heart-failure-volume-2022-01-01 2026-06-12T16:39:44.083Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/new-creatinine-cystatin-c-based-equations-estimate-gfr-2021-01-01 2026-06-12T16:51:52.589Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/chronic-kidney-disease-lancet-2021-01-01 2026-06-12T16:53:13.544Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/sglt2-inhibitors-patients-heart-failure-reduced-ejection-2020-01-01 2026-06-12T17:01:23.988Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/effect-dapagliflozin-worsening-heart-failure-cardiovascular-2020-01-01 2026-06-12T17:02:21.320Z monthly 0.65 https://hipa.ai/drug/dapagliflozin/updates/cardiovascular-renal-outcomes-empagliflozin-heart-failure-n-2020-01-01 2026-06-12T17:02:55.056Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/trial-results-posted-nct05140200-2026-05-26 2026-06-12T06:16:05.572Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/trial-results-posted-nct04718389-2026-05-18 2026-06-12T06:45:33.064Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/trial-results-posted-nct05243680-2026-01-15 2026-05-19T21:35:11.814Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/fda-approved-exdensur-depemokimab-bla-761458-2025-12-16 2026-05-11T05:51:34.783Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/trial-results-posted-nct05274750-2025-12-03 2026-05-12T17:38:19.019Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/phase-3-primary-completion-nct04718389-2025-09-14 2026-05-19T20:53:25.950Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/trial-results-posted-nct05281523-2025-09-09 2026-05-12T17:38:20.186Z monthly 0.65 https://hipa.ai/drug/depemokimab/updates/phase-3-primary-completion-nct05243680-2025-05-19 2026-05-19T21:35:12.247Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct05997277-2026-05-29 2026-06-12T06:09:56.172Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/phase-3-primary-completion-nct06973291-2026-04-22 2026-05-12T17:38:17.414Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct06042920-2026-04-17 2026-05-12T17:38:17.538Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/fda-approved-supplemental-application-sotyktu-2026-03-06 2026-05-11T04:57:17.283Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct05710185-2025-12-16 2026-05-12T17:38:18.798Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct06476834-2025-12-03 2026-05-12T17:38:19.009Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct04908202-2025-10-24 2026-05-19T21:04:11.874Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct04857034-2025-09-10 2026-05-12T17:38:20.173Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct05701995-2025-09-10 2026-05-19T22:18:00.389Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct06091956-2025-06-08 2026-05-12T17:38:21.371Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct04908189-2025-04-13 2026-05-12T17:38:22.270Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct05478499-2025-03-13 2026-05-12T18:13:32.270Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/trial-results-posted-nct05556265-2025-02-28 2026-05-12T18:16:47.838Z monthly 0.65 https://hipa.ai/drug/deucravacitinib/updates/once-daily-oral-icotrokinra-versus-placebo-once-daily-oral-2025-01-01 2026-06-12T15:54:42.941Z monthly 0.65 https://hipa.ai/drug/donanemab/updates/boxed-warning-present-label-kisunla-label-effective-2025-12-2025-12-30 2026-05-11T05:42:10.458Z monthly 0.65 https://hipa.ai/drug/donanemab/updates/trial-results-posted-nct05738486-2025-11-14 2026-05-19T22:20:15.617Z monthly 0.65 https://hipa.ai/drug/donanemab/updates/fda-approved-supplemental-application-kisunla-donanemab-azbt-2025-07-01 2026-05-12T18:06:23.814Z monthly 0.65 https://hipa.ai/drug/donanemab/updates/trial-results-posted-nct04640077-2025-06-13 2026-05-19T20:48:56.308Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/phase-3-primary-completion-nct06235086-2026-02-03 2026-05-19T22:58:24.287Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/mazdutide-versus-dulaglutide-chinese-adults-type-2-diabetes-2026-01-01 2026-05-12T17:37:23.567Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/trial-results-posted-nct05564039-2025-08-03 2026-05-19T22:05:58.938Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/phase-3-primary-completion-nct04255433-2025-06-12 2026-05-19T20:18:31.291Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/trial-results-posted-nct05254418-2025-04-20 2026-05-12T17:38:22.152Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/trial-results-posted-nct05659537-2025-02-05 2026-05-12T18:30:24.592Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/once-weekly-dulaglutide-treatment-youths-type-2-diabetes-n-2022-01-01 2026-06-12T16:41:06.990Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/dulaglutide-cardiovascular-outcomes-type-2-diabetes-rewind-2019-01-01 2026-06-12T17:10:19.954Z monthly 0.65 https://hipa.ai/drug/dulaglutide/updates/dulaglutide-renal-outcomes-type-2-diabetes-exploratory-2019-01-01 2026-06-12T17:12:33.902Z monthly 0.65 https://hipa.ai/drug/elagolix/updates/trial-results-posted-nct03271489-2025-07-22 2026-05-12T17:38:20.898Z monthly 0.65 https://hipa.ai/drug/elagolix/updates/phase-3-primary-completion-nct04173169-2025-05-02 2026-05-12T17:38:21.902Z monthly 0.65 https://hipa.ai/drug/elagolix/updates/trial-results-posted-nct05038878-2025-03-18 2026-05-12T17:38:22.898Z monthly 0.65 https://hipa.ai/drug/elagolix/updates/treatment-endometriosis-associated-pain-elagolix-oral-gnrh-2017-01-01 2026-06-12T17:26:03.200Z monthly 0.65 https://hipa.ai/drug/elranatamab/updates/boxed-warning-present-label-elrexfio-label-effective-2026-05-2026-05-14 2026-06-12T06:24:14.566Z monthly 0.65 https://hipa.ai/drug/elranatamab/updates/phase-3-primary-completion-nct05020236-2026-04-27 2026-05-19T21:14:14.638Z monthly 0.65 https://hipa.ai/drug/elranatamab/updates/trial-results-posted-nct05090566-2026-02-23 2026-05-19T21:19:54.452Z monthly 0.65 https://hipa.ai/drug/elranatamab/updates/fda-approved-supplemental-application-elrexfio-elranatamab-2025-07-10 2026-05-11T07:48:36.443Z monthly 0.65 https://hipa.ai/drug/elranatamab/updates/trial-results-posted-nct06504524-2025-06-27 2026-05-19T23:08:49.554Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/phase-3-primary-completion-nct07038356-2026-04-30 2026-05-12T17:38:17.087Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/phase-3-primary-completion-nct06571591-2026-04-16 2026-06-12T06:32:18.407Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/boxed-warning-present-label-synjardy-label-effective-2026-01-2026-01-30 2026-05-11T05:20:45.988Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/phase-3-primary-completion-nct05905965-2025-12-31 2026-05-12T17:38:18.633Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05073692-2025-11-21 2026-05-19T21:19:38.317Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/fda-approved-linagliptin-metformin-hydrochloride-linagliptin-2025-11-03 2026-05-11T06:28:05.960Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05081219-2025-10-21 2026-05-19T21:19:53.858Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05130463-2025-08-27 2026-05-19T21:25:22.051Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05350202-2025-08-26 2026-05-19T21:42:13.016Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05262764-2025-08-06 2026-05-19T21:35:13.706Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/phase-3-primary-completion-nct04603508-2025-04-30 2026-05-12T18:11:27.344Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05282121-2025-04-29 2026-05-12T17:38:22.008Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct03464045-2025-03-28 2026-05-12T17:38:22.717Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/fda-approved-supplemental-application-synjardy-empagliflozin-2025-03-07 2026-05-11T15:35:12.194Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/fda-approved-supplemental-application-synjardy-xr-2025-03-07 2026-05-11T15:35:30.910Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/long-term-effects-empagliflozin-patients-chronic-kidney-2025-01-01 2026-06-12T15:54:05.702Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/empagliflozin-after-acute-myocardial-infarction-n-engl-j-med-2024-01-01 2026-06-12T16:17:03.274Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/empagliflozin-patients-chronic-kidney-disease-n-engl-j-med-2023-01-01 2026-06-12T16:29:17.722Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/higher-dose-corticosteroids-patients-admitted-hospital-covid-2023-01-01 2026-06-12T16:30:48.450Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/aspirin-patients-admitted-hospital-covid-19-recovery-2022-01-01 2026-06-12T16:37:55.104Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/baricitinib-patients-admitted-hospital-covid-19-recovery-2022-01-01 2026-06-12T16:38:41.108Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/casirivimab-imdevimab-patients-admitted-hospital-covid-19-2022-01-01 2026-06-12T16:39:11.320Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/non-alcoholic-fatty-liver-disease-lancet-2022-01-01 2026-06-12T16:40:34.873Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/convalescent-plasma-patients-admitted-hospital-covid-19-2022-01-01 2026-06-12T16:41:46.772Z monthly 0.65 https://hipa.ai/drug/empagliflozin/updates/tocilizumab-patients-admitted-hospital-covid-19-recovery-2022-01-01 2026-06-12T16:43:14.073Z monthly 0.65 https://hipa.ai/drug/epcoritamab/updates/fda-approved-supplemental-application-epkinly-epcoritamab-2026-03-27 2026-05-11T04:46:42.973Z monthly 0.65 https://hipa.ai/drug/epcoritamab/updates/fda-approved-supplemental-application-epkinly-epcoritamab-2025-11-18 2026-05-11T06:17:25.277Z monthly 0.65 https://hipa.ai/drug/epcoritamab/updates/phase-3-primary-completion-nct07226752-2025-10-13 2026-05-19T23:21:27.583Z monthly 0.65 https://hipa.ai/drug/epcoritamab/updates/phase-3-primary-completion-nct04628494-2025-10-13 2026-05-19T20:48:54.659Z monthly 0.65 https://hipa.ai/drug/etavopivat/updates/phase-3-primary-completion-nct04624659-2026-02-06 2026-05-19T20:48:39.680Z monthly 0.65 https://hipa.ai/drug/etavopivat/updates/trial-results-posted-nct05568225-2025-10-22 2026-05-12T17:38:19.654Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/trial-results-posted-nct05144529-2026-05-05 2026-05-12T17:38:16.629Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/trial-results-posted-nct04608474-2026-04-16 2026-05-12T17:38:17.587Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/evolocumab-reduce-first-major-cardiovascular-events-patients-2026-01-01 2026-05-12T17:37:50.923Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/evolocumab-patients-without-previous-myocardial-infarction-2026-01-01 2026-05-12T17:38:04.203Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/phase-3-primary-completion-nct06081803-2025-12-31 2026-05-12T17:38:18.633Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/trial-results-posted-nct03515304-2025-11-24 2026-05-12T17:38:19.164Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/trial-results-posted-nct04082442-2025-10-23 2026-05-12T17:38:19.572Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/phase-3-primary-completion-nct03872401-2025-07-25 2026-05-12T17:38:20.809Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/trial-results-posted-nct04992065-2025-06-08 2026-05-12T17:38:21.406Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/evolocumab-pediatric-heterozygous-familial-2020-01-01 2026-06-12T17:03:07.235Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/clinical-efficacy-safety-achieving-very-low-ldl-cholesterol-2018-01-01 2026-06-12T17:21:44.839Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/effect-evolocumab-progression-coronary-disease-statin-2017-01-01 2026-06-12T17:27:06.542Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/evolocumab-clinical-outcomes-patients-cardiovascular-disease-2017-01-01 2026-06-12T17:27:20.145Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/cognitive-function-randomized-trial-evolocumab-n-engl-j-med-2017-01-01 2026-06-12T17:27:38.363Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/efficacy-tolerability-evolocumab-vs-ezetimibe-patients-2016-01-01 2026-06-12T17:31:45.544Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/inhibition-pcsk9-evolocumab-homozygous-familial-2015-01-01 2026-06-12T17:34:16.869Z monthly 0.65 https://hipa.ai/drug/evolocumab/updates/effect-evolocumab-ezetimibe-added-moderate-high-intensity-2014-01-01 2026-06-12T17:36:15.538Z monthly 0.65 https://hipa.ai/drug/eyp-1901/updates/trial-results-posted-nct05381948-2025-10-02 2026-05-12T17:38:19.886Z monthly 0.65 https://hipa.ai/drug/eyp-1901/updates/trial-results-posted-nct05383209-2025-07-28 2026-05-12T17:38:20.757Z monthly 0.65 https://hipa.ai/drug/fenebrutinib/updates/phase-3-primary-completion-nct04586010-2026-01-27 2026-05-12T17:38:18.377Z monthly 0.65 https://hipa.ai/drug/fenebrutinib/updates/phase-3-primary-completion-nct04544449-2025-09-17 2026-05-12T17:38:20.068Z monthly 0.65 https://hipa.ai/drug/fenebrutinib/updates/phase-3-primary-completion-nct04586023-2025-09-05 2026-05-12T17:38:20.249Z monthly 0.65 https://hipa.ai/drug/fianlimab/updates/phase-3-primary-completion-nct05352672-2026-03-12 2026-05-19T21:42:32.829Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/finerenone-type-1-diabetes-chronic-kidney-disease-n-engl-j-2026-01-01 2026-05-12T17:35:48.914Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/phase-3-primary-completion-nct05047263-2025-12-31 2026-05-12T17:38:18.634Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/phase-3-primary-completion-nct06244758-2025-11-25 2026-05-12T17:38:19.161Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/trial-results-posted-nct04435626-2025-08-26 2026-05-19T20:32:58.890Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/phase-3-primary-completion-nct05901831-2025-08-20 2026-05-19T22:32:43.191Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/fda-approved-supplemental-application-kerendia-finerenone-2025-07-11 2026-05-11T07:47:34.336Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/mineralocorticoid-receptor-antagonists-heart-failure-2024-01-01 2026-06-12T16:15:05.989Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/finerenone-heart-failure-mildly-reduced-preserved-ejection-2024-01-01 2026-06-12T16:17:49.550Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/cardiovascular-events-finerenone-kidney-disease-type-2-2021-01-01 2026-06-12T16:53:32.742Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/effect-finerenone-chronic-kidney-disease-outcomes-type-2-2020-01-01 2026-06-12T17:03:40.204Z monthly 0.65 https://hipa.ai/drug/finerenone/updates/prognostic-significance-left-ventricular-mass-change-during-2004-01-01 2026-06-12T17:39:17.812Z monthly 0.65 https://hipa.ai/drug/glofitamab/updates/boxed-warning-present-label-columvi-label-effective-2026-06-2026-06-03 2026-06-12T06:07:10.941Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/indication-usage-updated-tremfya-label-effective-2026-06-04-2026-06-04 2026-06-12T06:03:26.613Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct06039189-2026-05-01 2026-05-12T17:38:17.048Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct04882098-2026-02-04 2026-05-12T17:38:18.256Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct05083182-2026-01-12 2026-05-12T17:38:18.519Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct05528510-2025-12-09 2026-05-12T17:38:18.919Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct04936308-2025-12-08 2026-05-12T17:56:36.262Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/fda-approved-supplemental-application-tremfya-guselkumab-2025-09-26 2026-05-11T06:55:47.894Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/fda-approved-supplemental-application-tremfya-guselkumab-2025-09-26-015def 2026-05-12T17:01:29.266Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/fda-approved-supplemental-application-tremfya-guselkumab-2025-09-19 2026-05-12T18:02:42.578Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct04633447-2025-07-01 2026-05-12T17:38:21.128Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct05272150-2025-05-30 2026-05-19T21:35:36.971Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct04397263-2025-05-20 2026-05-12T17:38:21.633Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct03466411-2025-05-07 2026-05-12T17:38:21.821Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct06039189-2025-04-14 2026-05-12T17:38:22.270Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct03451851-2025-03-28 2026-05-12T17:38:22.685Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/fda-approved-supplemental-application-tremfya-guselkumab-2025-03-20 2026-05-11T09:07:32.469Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct05197049-2025-02-21 2026-05-12T18:20:39.799Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/efficacy-safety-intravenous-induction-subcutaneous-2025-01-01 2026-06-12T06:56:25.863Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/guselkumab-patients-moderately-severely-active-ulcerative-2025-01-01 2026-06-12T15:53:28.994Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct04882098-2024-12-30 2026-06-12T15:59:10.586Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct04936308-2024-10-28 2026-06-12T16:00:58.130Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct05528510-2024-04-02 2026-06-12T16:11:21.131Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct03451851-2023-07-19 2026-06-12T16:24:36.169Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct05197049-2023-07-04 2026-06-12T16:25:17.229Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/guselkumab-patients-active-psoriatic-arthritis-who-were-2020-01-01 2026-06-12T17:01:07.404Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/guselkumab-biologic-naive-patients-active-psoriatic-2020-01-01 2026-06-12T17:02:08.218Z monthly 0.65 https://hipa.ai/drug/guselkumab/updates/phase-3-primary-completion-nct03158285-2019-02-25 2026-06-12T17:09:39.625Z monthly 0.65 https://hipa.ai/drug/ianalumab/updates/phase-3-primary-completion-nct05648968-2026-02-20 2026-06-12T15:49:28.197Z monthly 0.65 https://hipa.ai/drug/ianalumab/updates/ianalumab-plus-eltrombopag-immune-thrombocytopenia-n-engl-j-2026-01-01 2026-05-12T17:53:33.516Z monthly 0.65 https://hipa.ai/drug/ianalumab/updates/phase-3-primary-completion-nct05653219-2025-06-19 2026-05-12T17:38:21.194Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct05192941-2026-04-14 2026-05-19T21:30:22.680Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/fda-approved-supplemental-application-leqvio-inclisiran-2026-02-12 2026-05-11T05:11:40.329Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/fda-approved-supplemental-application-leqvio-inclisiran-2026-02-12-f7bcd0 2026-05-12T17:01:29.311Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct04873934-2025-08-21 2026-05-12T17:38:20.462Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct05763875-2025-08-13 2026-05-19T22:21:28.163Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/fda-approved-supplemental-application-leqvio-inclisiran-2025-07-31 2026-05-11T07:33:32.683Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct04652726-2025-06-10 2026-05-12T17:38:21.370Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct04659863-2025-05-31 2026-05-12T17:38:21.471Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/trial-results-posted-nct05888103-2025-04-20 2026-05-12T17:38:22.153Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/inclisiran-treatment-heterozygous-familial-2022-01-01 2026-06-12T16:38:07.829Z monthly 0.65 https://hipa.ai/drug/inclisiran/updates/two-phase-3-trials-inclisiran-patients-elevated-ldl-2020-01-01 2026-06-12T17:04:16.402Z monthly 0.65 https://hipa.ai/drug/iptacopan/updates/boxed-warning-present-label-fabhalta-label-effective-2026-06-2026-06-08 2026-06-12T06:00:06.420Z monthly 0.65 https://hipa.ai/drug/iptacopan/updates/phase-3-primary-completion-nct04889430-2026-04-11 2026-05-12T17:38:17.635Z monthly 0.65 https://hipa.ai/drug/iptacopan/updates/trial-results-posted-nct05630001-2025-12-15 2026-05-12T17:38:18.847Z monthly 0.65 https://hipa.ai/drug/iptacopan/updates/fda-approved-supplemental-application-fabhalta-iptacopan-2025-03-20 2026-05-11T09:05:30.093Z monthly 0.65 https://hipa.ai/drug/iptacopan/updates/trial-results-posted-nct05086744-2025-03-19 2026-05-12T17:38:22.849Z monthly 0.65 https://hipa.ai/drug/itepekimab/updates/phase-3-primary-completion-nct04751487-2025-04-21 2026-05-12T17:38:22.152Z monthly 0.65 https://hipa.ai/drug/itepekimab/updates/phase-3-primary-completion-nct04701983-2025-04-11 2026-05-12T17:38:22.330Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/phase-3-primary-completion-nct06588283-2026-01-08 2026-05-19T23:11:52.501Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/phase-3-primary-completion-nct06588296-2025-11-18 2026-05-19T23:11:52.999Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/trial-results-posted-nct05855967-2025-08-22 2026-05-19T22:27:58.612Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/trial-results-posted-nct04979910-2025-05-20 2026-05-19T21:11:07.358Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/ixekizumab-patients-non-radiographic-axial-spondyloarthritis-2020-01-01 2026-06-12T17:01:52.880Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/ixekizumab-treatment-patients-active-psoriatic-arthritis-2017-01-01 2026-06-12T17:26:54.400Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/phase-3-trials-ixekizumab-moderate-severe-plaque-psoriasis-n-2016-01-01 2026-06-12T17:31:04.855Z monthly 0.65 https://hipa.ai/drug/ixekizumab/updates/comparison-ixekizumab-etanercept-placebo-moderate-severe-2015-01-01 2026-06-12T17:34:55.921Z monthly 0.65 https://hipa.ai/drug/lazertinib/updates/indication-usage-updated-lazcluze-label-effective-2026-05-05-2026-05-05 2026-05-12T17:24:25.496Z monthly 0.65 https://hipa.ai/drug/lazertinib/updates/fda-approved-supplemental-application-lazcluze-lazertinib-2025-08-14 2026-05-11T07:25:24.328Z monthly 0.65 https://hipa.ai/drug/lazertinib/updates/phase-3-primary-completion-nct04248829-2022-07-29 2026-06-12T16:33:10.045Z monthly 0.65 https://hipa.ai/drug/lecanemab/updates/trial-results-posted-nct01767311-2026-03-04 2026-05-19T19:01:44.162Z monthly 0.65 https://hipa.ai/drug/lecanemab/updates/fda-approved-lecanemab-autoinjector-lecanemab-irmb-bla-2025-08-29 2026-05-11T07:15:30.231Z monthly 0.65 https://hipa.ai/drug/lifileucel/updates/trial-results-posted-nct02360579-2025-12-09 2026-05-19T19:04:27.344Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-215245-2026-03-11 2026-05-11T04:55:35.958Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-217234-2026-02-24 2026-05-11T05:04:31.514Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-217063-2026-02-24 2026-05-11T05:05:06.348Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct01794143-2026-02-10 2026-05-19T19:01:44.688Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct06767748-2026-02-07 2026-05-12T17:38:18.226Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/boxed-warning-present-label-liraglutide-label-effective-2026-2026-01-30 2026-05-12T17:32:59.416Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/boxed-warning-present-label-liraglutide-label-effective-2026-2026-01-30-aeda4e 2026-05-12T17:01:29.355Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct05579249-2026-01-14 2026-05-19T22:07:26.116Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-217590-2026-01-14 2026-05-11T05:30:45.309Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct05952882-2025-12-31 2026-05-19T22:37:00.915Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct04955834-2025-12-31 2026-05-19T21:09:56.109Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct05641337-2025-12-30 2026-05-12T17:38:18.682Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/boxed-warning-present-label-liraglutide-label-effective-2025-2025-11-13 2026-05-11T06:20:19.591Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct06559722-2025-10-31 2026-05-19T23:11:21.424Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/boxed-warning-present-label-liraglutide-label-effective-2025-2025-10-16 2026-05-11T06:42:09.386Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-214568-2025-08-27 2026-05-11T07:16:34.075Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct04760626-2025-08-26 2026-05-19T20:56:07.373Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-215421-2025-07-22 2026-05-11T07:40:20.163Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct03260881-2025-07-08 2026-05-12T17:38:21.027Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct05463744-2025-06-24 2026-05-19T21:55:34.130Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct04848480-2025-06-12 2026-05-19T21:00:43.005Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct05275400-2025-06-03 2026-05-19T21:35:54.315Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct05362058-2025-05-16 2026-05-12T17:38:21.682Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct02516657-2025-04-20 2026-05-12T17:38:22.153Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/fda-approved-liraglutide-liraglutide-anda-218115-2025-04-02 2026-05-11T08:58:07.198Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct05965908-2025-03-30 2026-05-12T17:38:22.685Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct04881110-2025-03-03 2026-05-12T17:38:23.083Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/trial-results-posted-nct04770532-2025-02-20 2026-05-12T18:23:24.232Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/liraglutide-children-6-12-years-age-obesity-randomized-trial-2025-01-01 2026-06-12T15:56:22.865Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/phase-3-primary-completion-nct04775082-2023-08-01 2026-06-12T16:24:17.772Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/glycemia-reduction-type-2-diabetes-glycemic-outcomes-n-engl-2022-01-01 2026-06-12T16:37:30.158Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/effect-weekly-subcutaneous-semaglutide-vs-daily-liraglutide-2022-01-01 2026-06-12T16:40:51.175Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/glycemia-reduction-type-2-diabetes-microvascular-2022-01-01 2026-06-12T16:42:20.895Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/randomized-controlled-trial-liraglutide-adolescents-obesity-2020-01-01 2026-06-12T17:03:23.294Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/liraglutide-children-adolescents-type-2-diabetes-n-engl-j-2019-01-01 2026-06-12T17:10:37.008Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/oral-semaglutide-versus-subcutaneous-liraglutide-placebo-2019-01-01 2026-06-12T17:11:32.481Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/3-years-liraglutide-versus-placebo-type-2-diabetes-risk-2018-01-01 2026-06-12T17:21:15.637Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/effect-insulin-glargine-up-titration-vs-insulin-degludec-2016-01-01 2026-06-12T17:30:17.623Z monthly 0.65 https://hipa.ai/drug/liraglutide/updates/liraglutide-cardiovascular-outcomes-type-2-diabetes-n-engl-j-2016-01-01 2026-06-12T17:31:28.751Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/phase-3-primary-completion-nct05153239-2026-04-30 2026-05-12T17:38:17.143Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/phase-3-primary-completion-nct05153239-2026-04-10 2026-06-12T06:47:44.849Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/trial-results-posted-nct05740566-2026-01-05 2026-05-12T17:38:18.584Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/fda-approved-supplemental-application-zepzelca-lurbinectedin-2025-10-02 2026-05-11T06:51:29.941Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/trial-results-posted-nct05072106-2025-09-16 2026-05-12T17:38:20.070Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/trial-results-posted-nct05063318-2025-09-02 2026-05-12T17:38:20.321Z monthly 0.65 https://hipa.ai/drug/lurbinectedin/updates/trial-results-posted-nct05126433-2025-02-28 2026-05-12T18:15:53.926Z monthly 0.65 https://hipa.ai/drug/mavacamten/updates/phase-3-primary-completion-nct06253221-2025-11-25 2026-05-12T17:38:19.160Z monthly 0.65 https://hipa.ai/drug/mavacamten/updates/fda-approved-supplemental-application-camzyos-mavacamten-2025-04-17 2026-05-11T08:44:48.904Z monthly 0.65 https://hipa.ai/drug/mavacamten/updates/trial-results-posted-nct04766892-2025-03-20 2026-05-12T17:38:22.798Z monthly 0.65 https://hipa.ai/drug/mavacamten/updates/phase-3-primary-completion-nct05582395-2025-03-06 2026-05-12T17:38:23.014Z monthly 0.65 https://hipa.ai/drug/mazdutide/updates/trial-results-posted-nct06124807-2026-04-21 2026-05-12T17:38:17.537Z monthly 0.65 https://hipa.ai/drug/mazdutide/updates/phase-3-primary-completion-nct06184568-2025-09-17 2026-05-19T22:55:12.400Z monthly 0.65 https://hipa.ai/drug/mazdutide/updates/phase-3-primary-completion-nct06164873-2025-06-27 2026-05-19T22:54:29.088Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/fda-approved-supplemental-application-aqvesme-mitapivat-2025-12-23 2026-05-11T05:45:27.424Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/trial-results-posted-nct03853798-2025-11-18 2026-05-12T17:38:19.263Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/trial-results-posted-nct04770779-2025-05-25 2026-05-12T17:38:21.565Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/phase-3-primary-completion-nct05175105-2024-12-13 2026-06-12T15:59:42.057Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/phase-3-primary-completion-nct05144256-2024-05-03 2026-06-12T16:07:47.262Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/phase-3-primary-completion-nct04770779-2024-04-11 2026-06-12T16:10:47.744Z monthly 0.65 https://hipa.ai/drug/mitapivat/updates/phase-3-primary-completion-nct04770753-2023-11-13 2026-06-12T16:20:04.232Z monthly 0.65 https://hipa.ai/drug/mm120/updates/trial-results-posted-nct05200936-2025-04-13 2026-05-12T17:38:22.269Z monthly 0.65 https://hipa.ai/drug/mm120/updates/trial-results-posted-nct05407064-2025-03-20 2026-05-12T17:38:22.798Z monthly 0.65 https://hipa.ai/drug/nemolizumab/updates/trial-results-posted-nct04921345-2026-05-26 2026-06-12T06:18:21.137Z monthly 0.65 https://hipa.ai/drug/nemolizumab/updates/trial-results-posted-nct05214794-2026-02-13 2026-05-12T17:38:18.134Z monthly 0.65 https://hipa.ai/drug/nemolizumab/updates/trial-results-posted-nct04365387-2025-06-05 2026-05-12T17:38:21.420Z monthly 0.65 https://hipa.ai/drug/nemolizumab/updates/trial-results-posted-nct05075408-2025-02-20 2026-05-12T18:22:28.654Z monthly 0.65 https://hipa.ai/drug/nerandomilast/updates/trial-results-posted-nct06624072-2026-01-08 2026-05-12T17:38:18.583Z monthly 0.65 https://hipa.ai/drug/nerandomilast/updates/trial-results-posted-nct06393127-2025-12-01 2026-05-12T17:38:19.066Z monthly 0.65 https://hipa.ai/drug/nerandomilast/updates/trial-results-posted-nct06139302-2025-12-01 2026-05-12T17:38:19.066Z monthly 0.65 https://hipa.ai/drug/nerandomilast/updates/fda-approved-jascayd-nerandomilast-nda-218764-2025-10-07 2026-05-11T06:50:13.722Z monthly 0.65 https://hipa.ai/drug/nipocalimab/updates/trial-results-posted-nct06028438-2025-10-16 2026-05-19T22:43:42.007Z monthly 0.65 https://hipa.ai/drug/nipocalimab/updates/trial-results-posted-nct04991753-2025-08-22 2026-05-19T21:11:21.257Z monthly 0.65 https://hipa.ai/drug/nipocalimab/updates/trial-results-posted-nct04951622-2025-07-23 2026-05-12T17:38:20.862Z monthly 0.65 https://hipa.ai/drug/nipocalimab/updates/fda-approved-imaavy-nipocalimab-bla-761430-2025-04-29 2026-05-11T08:38:24.823Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04879368-2026-06-10 2026-06-12T05:57:39.968Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03958383-2026-06-03 2026-06-12T06:06:48.927Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02073123-2026-05-29 2026-06-12T06:10:52.431Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04514484-2026-05-28 2026-06-12T06:12:07.261Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04126070-2026-05-27 2026-06-12T15:48:07.527Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03646461-2026-05-22 2026-06-12T06:19:48.674Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04019964-2026-05-15 2026-06-12T06:46:03.078Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct01703949-2026-05-12 2026-06-12T06:27:07.438Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03767582-2026-05-11 2026-05-19T19:45:44.918Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03637543-2026-05-08 2026-05-19T19:36:52.964Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03355560-2026-05-06 2026-05-19T19:24:40.519Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04339738-2026-05-05 2026-05-12T17:38:16.625Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03367741-2026-04-29 2026-05-12T17:43:21.703Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02314169-2026-04-22 2026-05-12T17:38:17.469Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03981146-2026-04-22 2026-05-12T17:38:17.470Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct06101134-2026-04-09 2026-05-19T22:50:06.999Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03459222-2026-04-06 2026-05-12T17:38:17.681Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02873962-2026-04-01 2026-05-19T19:11:06.249Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04785820-2026-03-27 2026-05-12T17:46:39.735Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2026-03-20 2026-05-11T04:49:38.010Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03799445-2026-03-17 2026-05-12T17:38:17.851Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct06490536-2026-03-01 2026-05-12T17:38:17.977Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03358719-2026-02-27 2026-05-19T19:24:40.981Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct03383458-2026-02-27 2026-05-19T19:25:23.784Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03366766-2026-02-20 2026-05-12T17:38:18.074Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02224781-2026-02-18 2026-05-19T19:03:31.534Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02523469-2026-02-17 2026-05-19T19:06:31.467Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct03661320-2026-02-16 2026-05-19T19:38:32.782Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03785873-2026-02-13 2026-05-12T17:38:18.133Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03388190-2026-02-13 2026-05-12T17:38:18.162Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05921760-2026-02-12 2026-05-09T18:08:27.699Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04187404-2026-01-30 2026-05-12T17:38:18.328Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02648997-2026-01-26 2026-05-12T17:38:18.377Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct06587451-2026-01-23 2026-05-19T23:11:51.903Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03829722-2026-01-22 2026-05-12T17:38:18.432Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03994601-2026-01-20 2026-05-12T17:38:18.454Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04987203-2026-01-20 2026-05-19T21:11:20.787Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03267498-2026-01-12 2026-05-12T17:38:18.533Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04326257-2026-01-08 2026-05-12T17:38:18.534Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05002569-2026-01-08 2026-05-19T21:12:35.953Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct01968109-2026-01-06 2026-05-12T17:38:18.583Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/nivolumab-added-cisplatin-radiotherapy-versus-cisplatin-2026-01-01 2026-05-12T17:53:58.955Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/nivolumab-resected-stage-iii-iv-melanoma-9-years-n-engl-j-2026-01-01 2026-05-12T17:38:30.967Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct06640530-2025-12-31 2026-05-12T17:38:18.634Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct01658878-2025-12-24 2026-05-19T19:01:09.728Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03172624-2025-12-18 2026-05-12T17:38:18.776Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04349267-2025-12-17 2026-05-12T17:54:38.059Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04688658-2025-12-17 2026-05-12T17:38:18.797Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03347838-2025-12-12 2026-05-12T17:38:18.848Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04079712-2025-12-12 2026-05-12T17:38:18.848Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04021043-2025-12-03 2026-05-12T17:38:19.009Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03377361-2025-12-03 2026-05-19T19:25:06.581Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03388632-2025-12-03 2026-05-12T17:38:19.019Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-qvantig-2025-11-24 2026-05-11T06:10:12.064Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03718767-2025-11-24 2026-05-19T19:40:59.916Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03369223-2025-11-18 2026-05-12T17:38:19.263Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03021993-2025-11-12 2026-05-12T17:38:19.310Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02823990-2025-11-10 2026-05-12T17:38:19.358Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02275533-2025-11-06 2026-05-19T19:04:02.478Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02060188-2025-11-06 2026-05-12T17:38:19.359Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04205409-2025-11-03 2026-05-12T17:38:19.396Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03557359-2025-11-03 2026-05-12T17:38:19.396Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03914300-2025-10-31 2026-05-12T17:38:19.409Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02477826-2025-10-30 2026-05-19T19:05:51.492Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-qvantig-2025-10-27 2026-06-12T15:50:26.510Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-qvantig-2025-10-27-2f65f9 2026-05-12T17:01:29.401Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04050462-2025-10-16 2026-05-19T20:02:02.139Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03573947-2025-10-14 2026-05-19T19:33:33.812Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct05111626-2025-10-14 2026-05-12T17:38:19.753Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct03520686-2025-10-13 2026-06-12T06:50:19.563Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03595124-2025-10-10 2026-05-19T19:35:13.151Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03184870-2025-10-09 2026-05-19T19:19:30.991Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05407675-2025-10-03 2026-05-12T17:38:19.848Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04987203-2025-09-30 2026-05-12T17:38:19.906Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02408861-2025-09-23 2026-05-19T19:04:27.888Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04008030-2025-09-22 2026-05-12T17:38:19.977Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03446040-2025-09-18 2026-05-12T17:38:20.006Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03036098-2025-09-18 2026-05-19T19:14:35.935Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04149574-2025-09-16 2026-05-12T17:38:20.070Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03195478-2025-09-15 2026-05-12T17:38:20.112Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03937219-2025-09-10 2026-05-19T19:53:28.582Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04695977-2025-09-05 2026-05-19T20:51:53.885Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04611126-2025-08-12 2026-05-12T17:38:20.574Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03636477-2025-08-12 2026-05-19T19:36:52.425Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03697564-2025-08-06 2026-05-12T17:38:20.643Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03739619-2025-08-06 2026-05-19T19:43:09.635Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct05625399-2025-08-04 2026-05-19T22:10:59.802Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct05678673-2025-07-31 2026-05-12T17:38:20.699Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04810078-2025-07-29 2026-05-12T17:38:20.755Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02681302-2025-07-25 2026-05-19T19:08:33.803Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04026412-2025-07-24 2026-05-12T17:38:20.846Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04891770-2025-07-24 2026-05-12T17:38:20.861Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03547999-2025-07-22 2026-05-12T17:38:20.863Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02553642-2025-07-22 2026-05-19T19:06:44.391Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04493203-2025-07-15 2026-05-12T17:38:20.967Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct05328908-2025-07-14 2026-05-19T21:40:54.660Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04513522-2025-07-11 2026-05-12T17:38:21.025Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03117309-2025-07-10 2026-05-12T17:38:21.026Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04879368-2025-07-09 2026-05-12T17:38:21.026Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct06022861-2025-06-30 2026-05-12T17:38:21.129Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04282109-2025-06-26 2026-05-12T17:38:21.144Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03815942-2025-06-25 2026-05-12T17:38:21.179Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03522246-2025-06-24 2026-05-19T19:31:29.986Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04334759-2025-06-20 2026-05-12T17:38:21.193Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03400332-2025-06-19 2026-05-19T19:26:35.927Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03907488-2025-06-12 2026-05-12T17:38:21.365Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05169684-2025-06-10 2026-05-12T17:38:21.370Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2025-05-23 2026-05-11T16:16:51.474Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03944915-2025-05-11 2026-05-12T17:38:21.773Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03107182-2025-05-06 2026-05-12T17:38:21.873Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04526730-2025-05-06 2026-05-12T17:38:21.873Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03952585-2025-05-02 2026-05-12T17:38:21.903Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct06003075-2025-04-30 2026-05-12T17:38:21.972Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03689699-2025-04-29 2026-05-12T17:38:21.974Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03110107-2025-04-24 2026-05-12T17:38:22.080Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03719131-2025-04-22 2026-05-12T17:38:22.121Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02913313-2025-04-20 2026-05-12T17:38:22.152Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04907539-2025-04-16 2026-05-12T17:38:22.206Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct06094296-2025-04-16 2026-05-12T17:38:22.269Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2025-04-11 2026-05-11T08:50:34.798Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2025-04-08 2026-05-11T08:53:38.541Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04938232-2025-04-03 2026-05-12T17:38:22.507Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04698187-2025-04-02 2026-05-12T17:38:22.604Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct05907122-2025-03-26 2026-05-12T17:38:22.739Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03377023-2025-03-25 2026-05-12T17:38:22.740Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05543629-2025-03-18 2026-05-12T17:38:22.856Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04623775-2025-03-18 2026-05-12T17:38:22.857Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04761198-2025-03-17 2026-05-12T17:38:22.904Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03285321-2025-03-11 2026-05-12T17:38:22.955Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03727061-2025-03-11 2026-05-12T17:38:22.955Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05061017-2025-03-07 2026-05-12T17:38:23.012Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03158129-2025-03-05 2026-05-12T17:38:23.059Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04741438-2025-02-28 2026-05-12T17:38:23.114Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05297565-2025-02-27 2026-05-12T18:17:31.541Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03047928-2025-02-20 2026-05-12T18:21:00.590Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03656718-2025-02-20 2026-05-12T18:21:17.775Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03190174-2025-02-17 2026-05-12T18:24:23.784Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04552223-2025-02-13 2026-05-12T18:25:30.047Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03439891-2025-02-11 2026-05-12T18:25:59.268Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02927769-2025-02-10 2026-05-12T18:26:21.584Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04056910-2025-02-06 2026-05-12T18:29:37.405Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct04879368-2025-01-14 2026-06-12T06:54:42.468Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/nivolumab-plus-ipilimumab-versus-lenvatinib-sorafenib-first-2025-01-01 2026-06-12T06:55:14.163Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/final-10-year-outcomes-nivolumab-plus-ipilimumab-advanced-2025-01-01 2026-06-12T06:56:47.213Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/nivolumab-plus-ipilimumab-versus-nivolumab-microsatellite-2025-01-01 2026-06-12T15:55:23.742Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/overall-survival-neoadjuvant-nivolumab-plus-chemotherapy-2025-01-01 2026-06-12T15:57:04.632Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-opdivo-qvantig-nivolumab-hyaluronidase-nvhy-bla-2024-12-27 2026-06-12T15:59:28.683Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2024-10-03 2026-06-12T16:02:10.800Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct03907488-2024-03-31 2026-06-12T16:11:39.923Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2024-03-06 2026-06-12T16:11:58.527Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2024-01-26 2026-06-12T16:13:10.077Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/pembrolizumab-versus-placebo-adjuvant-therapy-completely-2024-01-01 2026-06-12T16:16:05.328Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/perioperative-nivolumab-resectable-lung-cancer-n-engl-j-med-2024-01-01 2026-06-12T16:16:45.124Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/nivolumab-avd-advanced-stage-classic-hodgkin-s-lymphoma-n-2024-01-01 2026-06-12T16:16:17.126Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/tivozanib-plus-nivolumab-versus-tivozanib-monotherapy-2024-01-01 2026-06-12T16:17:37.861Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2023-10-13 2026-06-12T16:21:40.380Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct02224781-2023-09-30 2026-06-12T16:22:12.801Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct03055013-2023-05-24 2026-06-12T16:26:09.583Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2023-02-15 2026-06-12T16:27:26.797Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2022-07-14 2026-06-12T16:33:21.514Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2022-05-27 2026-06-12T16:33:35.440Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2022-05-11 2026-06-12T16:34:04.948Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2022-03-04 2026-06-12T16:35:47.605Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2021-08-19 2026-06-12T16:45:58.208Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2021-07-15 2026-06-12T16:47:15.207Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2021-05-20 2026-06-12T16:48:13.303Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2021-04-16 2026-06-12T16:48:43.200Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2021-01-22 2026-06-12T16:50:59.354Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-10-02 2026-06-12T16:55:40.079Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-09-18 2026-06-12T16:56:22.697Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-06-10 2026-06-12T16:58:33.368Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-05-26 2026-06-12T16:59:02.848Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-05-15 2026-06-12T16:59:30.525Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2020-03-10 2026-06-12T17:00:04.321Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct02785952-2019-12-19 2026-06-12T17:05:09.953Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2019-04-18 2026-06-12T17:07:36.603Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2019-03-07 2026-06-12T17:08:45.804Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-08-16 2026-06-12T17:15:09.979Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-07-10 2026-06-12T17:15:42.321Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-04-16 2026-06-12T17:17:56.934Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-03-05 2026-06-12T17:18:10.724Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-02-15 2026-06-12T17:18:37.339Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2018-01-09 2026-06-12T17:19:05.255Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2017-12-20 2026-06-12T17:21:58.239Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2017-09-22 2026-06-12T17:22:39.362Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2017-07-31 2026-06-12T17:22:53.022Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/phase-3-primary-completion-nct02231749-2017-06-26 2026-06-12T17:23:18.183Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2017-04-25 2026-06-12T17:24:46.414Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2017-02-02 2026-06-12T17:25:34.706Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2016-11-10 2026-06-12T17:27:57.719Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2016-10-04 2026-06-12T17:28:36.718Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2016-09-13 2026-06-12T17:28:51.281Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2016-05-17 2026-06-12T17:29:40.016Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2016-01-23 2026-06-12T17:29:57.114Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2015-11-23 2026-06-12T17:32:26.279Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2015-10-09 2026-06-12T17:32:40.759Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-supplemental-application-opdivo-nivolumab-2015-09-30 2026-06-12T17:33:07.734Z monthly 0.65 https://hipa.ai/drug/nivolumab/updates/fda-approved-opdivo-nivolumab-bla-125554-2014-12-22 2026-06-12T17:35:33.701Z monthly 0.65 https://hipa.ai/drug/obicetrapib/updates/trial-results-posted-nct06005597-2025-10-08 2026-05-19T22:42:21.910Z monthly 0.65 https://hipa.ai/drug/obicetrapib/updates/trial-results-posted-nct05142722-2025-09-19 2026-05-19T21:26:00.049Z monthly 0.65 https://hipa.ai/drug/obicetrapib/updates/trial-results-posted-nct05425745-2025-06-11 2026-05-19T21:52:43.427Z monthly 0.65 https://hipa.ai/drug/olezarsen/updates/trial-results-posted-nct05355402-2026-04-23 2026-05-12T17:38:17.414Z monthly 0.65 https://hipa.ai/drug/olezarsen/updates/trial-results-posted-nct04568434-2025-03-06 2026-05-12T18:14:47.669Z monthly 0.65 https://hipa.ai/drug/olpasiran/updates/trial-results-posted-nct04987320-2025-02-10 2026-05-12T18:28:19.686Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05936138-2026-06-09 2026-06-12T05:59:54.377Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05051566-2026-05-29 2026-06-12T06:11:09.626Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05469126-2026-05-27 2026-06-12T06:12:43.130Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05882032-2026-05-27 2026-06-12T15:47:16.215Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05341089-2026-05-27 2026-06-12T06:14:24.162Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct06085482-2026-05-27 2026-06-12T06:14:59.595Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct04680767-2026-05-26 2026-06-12T06:15:47.971Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05313802-2026-05-26 2026-06-12T06:16:51.743Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct04426474-2026-05-26 2026-06-12T06:17:14.356Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct06704763-2026-05-26 2026-06-12T06:17:40.748Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05110794-2026-05-26 2026-06-12T06:18:01.159Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05573230-2026-05-26 2026-06-12T06:18:53.757Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct06186622-2026-05-22 2026-06-12T06:20:54.904Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05971940-2026-04-22 2026-05-12T17:38:17.448Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/fda-approved-foundayo-orforglipron-nda-220934-2026-04-01 2026-05-11T04:45:05.065Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct05803421-2026-03-16 2026-05-19T22:24:12.418Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct06584916-2025-11-21 2026-05-19T23:11:50.821Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct06109311-2025-09-15 2026-05-19T22:50:22.598Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct06045221-2025-08-22 2026-05-19T22:45:24.292Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct05872620-2025-08-08 2026-05-19T22:30:15.453Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct05869903-2025-07-25 2026-05-19T22:29:46.406Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct05931380-2025-06-19 2026-05-19T22:35:49.339Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct06010004-2025-06-05 2026-05-19T22:42:22.483Z monthly 0.65 https://hipa.ai/drug/orforglipron/updates/phase-3-primary-completion-nct05971940-2025-04-03 2026-05-12T17:38:22.603Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct04351555-2026-06-05 2026-06-12T06:02:38.288Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct06630325-2026-04-28 2026-05-12T17:38:17.298Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct06323148-2026-03-31 2026-05-19T23:00:56.035Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct02971501-2026-03-17 2026-05-12T17:38:17.828Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct03778229-2026-02-10 2026-05-12T17:38:18.187Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct04765059-2026-01-13 2026-05-19T20:56:22.524Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/savolitinib-plus-osimertinib-versus-chemotherapy-advanced-2026-01-01 2026-05-12T17:36:45.624Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct05015608-2025-12-15 2026-05-19T21:14:14.022Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct04695925-2025-11-01 2026-05-12T17:38:19.408Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct02856893-2025-10-31 2026-05-19T19:10:44.480Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct05215951-2025-10-15 2026-05-19T21:32:54.384Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct05015608-2025-08-22 2026-06-12T06:51:12.369Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct03831932-2025-06-19 2026-05-12T17:38:21.237Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct05382728-2025-05-31 2026-05-19T21:46:51.304Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct03521154-2025-04-03 2026-05-12T18:12:18.865Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/trial-results-posted-nct03414814-2025-02-11 2026-05-12T18:25:43.318Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/survival-osimertinib-plus-chemotherapy-egfr-mutated-advanced-2025-01-01 2026-06-12T15:53:50.778Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/overall-survival-amivantamab-lazertinib-egfr-mutated-2025-01-01 2026-06-12T15:57:17.848Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/phase-3-primary-completion-nct04351555-2024-10-15 2026-06-12T16:01:53.825Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/osimertinib-after-chemoradiotherapy-stage-iii-egfr-mutated-2024-01-01 2026-06-12T16:18:32.138Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/amivantamab-plus-lazertinib-previously-untreated-egfr-2024-01-01 2026-06-12T16:19:15.736Z monthly 0.65 https://hipa.ai/drug/osimertinib/updates/osimertinib-without-chemotherapy-egfr-mutated-advanced-nsclc-2023-01-01 2026-06-12T16:28:18.307Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/phase-3-primary-completion-nct07214740-2025-12-12 2026-05-12T17:55:58.782Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/phase-3-primary-completion-nct03531255-2025-11-29 2026-05-12T17:38:19.066Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/trial-results-posted-nct05148299-2025-11-28 2026-05-12T17:38:19.108Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/trial-results-posted-nct05096403-2025-10-30 2026-05-12T18:00:16.943Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/phase-3-primary-completion-nct04770545-2025-09-05 2026-05-12T17:38:20.249Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/phase-3-primary-completion-nct03531255-2025-09-04 2026-06-12T06:50:54.528Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/trial-results-posted-nct05067127-2025-08-06 2026-05-12T17:38:20.676Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/fda-approved-supplemental-application-empaveli-pegcetacoplan-2025-07-28 2026-05-11T07:37:26.985Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/trial-results-posted-nct04579666-2025-04-24 2026-05-12T17:38:22.081Z monthly 0.65 https://hipa.ai/drug/pegcetacoplan/updates/trial-results-posted-nct04572854-2025-02-07 2026-05-12T18:28:59.991Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03516981-2026-06-08 2026-06-12T06:00:52.730Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04895722-2026-06-08 2026-06-12T06:01:36.896Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04955743-2026-06-04 2026-06-12T06:06:07.189Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04895735-2026-06-04 2026-06-12T06:33:36.512Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03244384-2026-06-01 2026-06-12T06:08:54.661Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct02954874-2026-05-31 2026-06-12T06:09:11.473Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05203445-2026-05-29 2026-06-12T06:09:40.732Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03095781-2026-05-22 2026-06-12T06:41:12.088Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03430700-2026-05-20 2026-06-12T06:43:39.813Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02444741-2026-05-15 2026-06-12T06:47:22.853Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02841748-2026-05-13 2026-06-12T06:25:43.696Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04165096-2026-05-13 2026-06-12T06:26:20.214Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04369937-2026-05-13 2026-06-12T06:26:34.389Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04746924-2026-05-12 2026-06-12T06:26:53.400Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04414540-2026-05-08 2026-05-19T20:31:15.702Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02399371-2026-05-08 2026-05-12T17:38:23.412Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03349450-2026-05-06 2026-05-12T17:38:16.579Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03144466-2026-05-05 2026-05-12T17:38:16.627Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05379972-2026-05-04 2026-05-20T20:24:18.305Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03752333-2026-05-04 2026-05-12T17:38:16.779Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04475939-2026-05-01 2026-05-12T17:38:16.849Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02837263-2026-05-01 2026-05-12T17:38:16.925Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05048797-2026-04-30 2026-05-12T17:38:17.179Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03867084-2026-04-24 2026-05-19T19:50:03.051Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-qlex-2026-04-24 2026-06-12T06:31:47.683Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02562625-2026-04-23 2026-05-12T17:38:17.389Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02587455-2026-04-23 2026-05-12T17:38:17.413Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04393350-2026-04-20 2026-05-19T20:28:17.144Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03634241-2026-04-16 2026-05-12T17:38:17.552Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05232851-2026-04-14 2026-05-12T17:44:19.653Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04225117-2026-04-13 2026-05-12T17:38:17.635Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03236935-2026-04-09 2026-05-19T19:20:35.146Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04869137-2026-04-08 2026-05-12T17:38:17.661Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05077709-2026-04-08 2026-05-19T21:19:38.804Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct06099782-2026-04-08 2026-05-19T22:49:48.854Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03428802-2026-04-03 2026-05-12T17:38:17.681Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct06348199-2026-03-31 2026-05-12T17:38:17.721Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03983668-2026-03-30 2026-05-19T19:56:42.019Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04234113-2026-03-27 2026-05-19T20:16:41.933Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03197506-2026-03-25 2026-05-19T19:19:32.052Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03568058-2026-03-24 2026-05-12T17:38:17.768Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04216316-2026-03-24 2026-05-12T17:38:17.779Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05059470-2026-03-23 2026-05-12T17:47:08.911Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03753659-2026-03-23 2026-05-12T17:38:17.781Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03276832-2026-03-19 2026-05-19T19:21:05.527Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02642809-2026-03-18 2026-05-12T17:38:17.828Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct06159790-2026-03-16 2026-05-12T17:38:17.877Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03386357-2026-03-12 2026-05-19T19:25:24.296Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct06698042-2026-03-12 2026-05-19T23:12:55.861Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03239145-2026-03-12 2026-05-12T17:38:17.928Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02402920-2026-03-10 2026-05-12T17:38:17.929Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05116189-2026-03-09 2026-05-19T21:23:59.242Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02858869-2026-03-09 2026-05-19T19:10:44.945Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04222972-2026-03-05 2026-05-19T20:14:45.363Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04214249-2026-03-04 2026-05-19T20:14:44.787Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03272334-2026-02-27 2026-05-19T19:21:04.991Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02446457-2026-02-27 2026-05-12T17:38:18.014Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04268277-2026-02-27 2026-05-12T17:49:34.452Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02778685-2026-02-24 2026-05-12T17:38:18.033Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03990961-2026-02-20 2026-05-19T19:56:42.518Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04030455-2026-02-17 2026-05-12T17:38:18.115Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03123276-2026-02-13 2026-05-12T17:38:18.171Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04848337-2026-02-12 2026-05-12T17:38:18.171Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03559049-2026-02-12 2026-05-12T17:38:18.172Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03993353-2026-02-12 2026-05-19T19:56:55.185Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2026-02-10 2026-06-12T15:49:54.158Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-qlex-2026-02-10 2026-06-12T06:49:08.649Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03237572-2026-02-09 2026-05-19T19:20:35.645Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04332653-2026-02-09 2026-05-19T20:24:20.476Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03727880-2026-02-04 2026-05-19T19:41:57.822Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04166734-2026-02-04 2026-05-12T17:38:18.275Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03815058-2026-01-30 2026-05-12T17:52:41.516Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05814666-2026-01-30 2026-05-19T22:24:27.475Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04856189-2026-01-29 2026-05-12T17:38:18.328Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04260529-2026-01-29 2026-05-12T17:38:18.328Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03436056-2026-01-29 2026-05-12T17:38:18.329Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03474497-2026-01-29 2026-05-19T19:30:52.115Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03924856-2026-01-26 2026-05-19T19:53:09.599Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04095689-2026-01-23 2026-05-19T20:05:34.795Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05070247-2026-01-22 2026-05-19T21:19:37.773Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02971748-2026-01-22 2026-05-12T17:38:18.432Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04210115-2026-01-21 2026-06-12T06:49:19.600Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct02684292-2026-01-14 2026-05-19T19:08:34.369Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03210662-2026-01-13 2026-05-12T17:38:18.484Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04657991-2026-01-12 2026-05-19T20:50:02.945Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03873818-2026-01-09 2026-05-19T19:51:01.348Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04221945-2026-01-05 2026-05-12T17:38:18.584Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03844750-2025-12-31 2026-05-12T17:38:18.623Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04601857-2025-12-31 2026-05-12T17:38:18.661Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04214067-2025-12-30 2026-05-12T17:38:18.681Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03734809-2025-12-24 2026-05-12T17:38:18.729Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05141357-2025-12-24 2026-05-12T17:38:18.737Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03095352-2025-12-22 2026-05-19T19:16:15.462Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04547504-2025-12-22 2026-05-12T17:38:18.737Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02819752-2025-12-18 2026-05-19T19:10:25.006Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03310957-2025-12-12 2026-05-12T17:38:18.855Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04381650-2025-12-10 2026-05-12T17:38:18.896Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03595683-2025-12-08 2026-05-19T19:35:13.994Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03260504-2025-12-08 2026-05-12T17:38:18.969Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03007732-2025-12-05 2026-05-19T19:14:18.524Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04090528-2025-12-05 2026-05-19T20:04:57.547Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02437071-2025-12-05 2026-05-12T17:38:18.971Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04704219-2025-12-03 2026-05-19T20:52:40.695Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04373031-2025-12-02 2026-05-19T20:26:37.031Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05383170-2025-11-28 2026-05-12T17:38:19.100Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04662710-2025-11-28 2026-05-12T17:38:19.109Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04570332-2025-11-26 2026-05-19T20:45:21.051Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05633602-2025-11-26 2026-05-12T17:38:19.116Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02706353-2025-11-21 2026-05-19T19:08:56.201Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-11-21 2026-05-11T06:12:10.067Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-qlex-2025-11-21 2026-06-12T06:50:04.963Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04454489-2025-11-19 2026-05-12T17:38:19.213Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04854499-2025-11-19 2026-05-19T21:00:58.592Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05775289-2025-11-19 2026-05-19T22:22:39.551Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05052723-2025-11-19 2026-05-19T21:17:45.852Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05256381-2025-11-17 2026-05-19T21:35:12.775Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03797326-2025-11-17 2026-05-19T19:46:22.710Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05226598-2025-11-13 2026-05-12T17:38:19.310Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02959463-2025-11-13 2026-05-12T17:38:19.310Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct06212752-2025-11-12 2026-05-12T17:38:19.310Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03160079-2025-11-10 2026-05-12T17:38:19.340Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04370509-2025-11-05 2026-05-12T17:38:19.359Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03396445-2025-11-05 2026-05-12T17:38:19.396Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03069378-2025-10-29 2026-05-12T17:38:19.503Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05469178-2025-10-29 2026-05-12T17:38:19.503Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04828486-2025-10-29 2026-05-12T17:38:19.503Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04700124-2025-10-27 2026-05-19T20:52:14.046Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05091346-2025-10-24 2026-05-19T21:20:18.631Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03728972-2025-10-23 2026-05-12T17:38:19.602Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02882282-2025-10-23 2026-05-12T17:38:19.607Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03049618-2025-10-22 2026-05-19T19:14:56.092Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct06046482-2025-10-22 2026-05-12T17:38:19.654Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03036488-2025-10-14 2026-05-12T17:38:19.753Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02964013-2025-10-14 2026-05-12T17:38:19.754Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02621151-2025-10-07 2026-05-12T17:38:19.838Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03978624-2025-10-07 2026-05-19T19:55:57.541Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03426891-2025-10-06 2026-05-19T19:28:38.098Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05263492-2025-10-02 2026-05-12T17:38:19.849Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05179603-2025-10-02 2026-05-19T21:28:39.448Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04914897-2025-10-02 2026-05-19T21:04:30.553Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04747054-2025-10-01 2026-05-12T17:38:19.903Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04768686-2025-09-25 2026-05-12T17:38:19.937Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03184571-2025-09-25 2026-05-12T17:38:19.954Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05061420-2025-09-22 2026-05-12T17:38:19.991Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-keytruda-qlex-pembrolizumab-berahyaluronidase-2025-09-19 2026-06-12T06:50:40.098Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04383743-2025-09-18 2026-05-12T17:38:20.008Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05036681-2025-09-17 2026-05-12T17:38:20.009Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05600309-2025-09-17 2026-05-19T22:09:21.648Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05064059-2025-09-17 2026-05-19T21:19:12.472Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03307759-2025-09-15 2026-05-19T19:22:24.401Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03740165-2025-09-12 2026-05-19T19:43:10.632Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04430738-2025-09-09 2026-05-19T20:32:57.893Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03347617-2025-09-09 2026-05-19T19:24:10.312Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04879849-2025-09-04 2026-05-12T17:38:20.272Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03715205-2025-08-29 2026-05-19T19:40:59.459Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03899805-2025-08-28 2026-05-12T17:38:20.322Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05092360-2025-08-28 2026-05-19T21:20:19.114Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04738487-2025-08-26 2026-05-19T20:54:31.979Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03957551-2025-08-24 2026-05-12T17:38:20.460Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04246177-2025-08-19 2026-05-12T17:38:20.507Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04936230-2025-08-17 2026-05-12T17:38:20.507Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04164979-2025-08-11 2026-05-12T17:38:20.575Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03695471-2025-08-11 2026-05-12T17:38:20.575Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02475213-2025-08-11 2026-05-19T19:05:51.025Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04837196-2025-08-08 2026-05-12T17:38:20.642Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03444376-2025-07-30 2026-05-12T17:38:20.751Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct06280196-2025-07-30 2026-05-12T17:38:20.753Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05691829-2025-07-29 2026-05-12T17:38:20.756Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05722015-2025-07-28 2026-05-12T17:38:20.807Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03316872-2025-07-25 2026-05-19T19:22:38.053Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04904185-2025-07-25 2026-05-19T21:03:44.517Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05308901-2025-07-25 2026-05-12T17:38:20.845Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-07-24 2026-05-11T07:39:51.221Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03833167-2025-07-22 2026-05-12T17:38:20.864Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03734692-2025-07-20 2026-05-12T17:38:20.919Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02940496-2025-07-15 2026-05-12T17:38:20.955Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04120454-2025-07-11 2026-05-12T17:38:20.968Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02635360-2025-07-03 2026-05-12T17:38:21.088Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02411656-2025-07-02 2026-05-12T17:38:21.090Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03884556-2025-07-02 2026-05-19T19:51:37.134Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05104567-2025-07-01 2026-05-19T21:22:46.167Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05055908-2025-07-01 2026-05-19T21:17:59.610Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05634577-2025-06-19 2026-05-12T17:38:21.194Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03867175-2025-06-13 2026-05-12T17:38:21.282Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03325101-2025-06-12 2026-05-12T17:38:21.291Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-06-12 2026-05-11T08:05:38.520Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02899793-2025-06-11 2026-05-12T17:38:21.361Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03582475-2025-06-10 2026-05-19T19:33:55.168Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-06-06 2026-05-11T08:08:31.884Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03924895-2025-06-06 2026-05-12T17:38:21.419Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-06-03 2026-05-11T08:12:33.271Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04251169-2025-06-03 2026-05-19T20:18:07.081Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04849364-2025-05-31 2026-05-19T21:00:43.487Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04746924-2025-05-30 2026-05-19T20:55:38.542Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04448886-2025-05-30 2026-05-19T20:33:35.242Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02720068-2025-05-30 2026-05-12T17:38:21.516Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03242915-2025-05-30 2026-05-19T19:20:36.157Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05155254-2025-05-30 2026-05-19T21:26:52.275Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03025035-2025-05-29 2026-05-19T19:14:19.342Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04428151-2025-05-25 2026-05-12T17:38:21.565Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-05-22 2026-05-11T08:20:24.809Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03299088-2025-05-21 2026-05-12T17:38:21.602Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02799095-2025-05-21 2026-05-12T17:38:21.631Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03035331-2025-05-16 2026-05-12T17:38:21.669Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04171219-2025-05-16 2026-05-12T17:38:21.683Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03835819-2025-05-15 2026-05-12T17:38:21.683Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03390504-2025-05-14 2026-05-12T18:10:47.205Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04082572-2025-05-13 2026-05-12T17:38:21.729Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04383938-2025-05-13 2026-05-12T17:38:21.729Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct06643117-2025-05-13 2026-05-12T17:38:21.729Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05311176-2025-05-11 2026-05-12T17:38:21.760Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03286114-2025-05-11 2026-05-12T17:38:21.761Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03924869-2025-05-11 2026-05-12T17:38:21.762Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05323656-2025-05-09 2026-05-12T17:38:21.773Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04967417-2025-05-09 2026-05-12T17:38:21.815Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04949256-2025-05-08 2026-05-12T17:38:21.816Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03747120-2025-05-08 2026-05-12T17:38:21.820Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02638090-2025-05-04 2026-05-12T17:38:21.900Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03414229-2025-05-02 2026-05-12T17:38:21.901Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04483544-2025-04-29 2026-05-12T17:38:21.974Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03867175-2025-04-21 2026-05-12T17:38:22.145Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-04-21 2026-05-11T08:42:05.642Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02875132-2025-04-18 2026-05-12T17:38:22.198Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03401853-2025-04-18 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04925986-2025-04-17 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03609359-2025-04-16 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03179436-2025-04-08 2026-05-12T17:38:22.379Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04633278-2025-04-08 2026-05-12T17:38:22.507Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05665595-2025-04-06 2026-05-12T17:38:22.507Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04317066-2025-04-06 2026-05-12T17:38:22.507Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03197467-2025-04-04 2026-05-12T17:38:22.508Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04479241-2025-03-25 2026-05-12T17:38:22.740Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05267470-2025-03-25 2026-05-12T17:38:22.740Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03526887-2025-03-24 2026-05-12T17:38:22.769Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04267120-2025-03-21 2026-05-12T17:38:22.798Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03867084-2025-03-20 2026-05-12T17:38:22.798Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02437136-2025-03-20 2026-05-12T17:38:22.849Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-03-19 2026-05-11T09:08:41.956Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03914612-2025-03-18 2026-05-12T17:38:22.857Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02365766-2025-03-18 2026-05-12T18:13:13.476Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04524689-2025-03-17 2026-05-12T17:38:22.905Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04907851-2025-03-17 2026-05-12T17:38:22.905Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03615326-2025-03-17 2026-05-12T17:38:22.906Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04284787-2025-03-13 2026-05-12T17:38:22.920Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05446129-2025-03-13 2026-05-12T17:38:22.955Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03137771-2025-03-11 2026-05-12T17:38:22.961Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04032847-2025-03-10 2026-05-12T17:38:22.996Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04032704-2025-03-10 2026-05-12T17:38:22.997Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02783300-2025-03-10 2026-05-12T17:38:23.012Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03747484-2025-03-06 2026-05-12T18:15:19.075Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05116189-2025-03-05 2026-05-12T17:38:23.059Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03396926-2025-02-28 2026-05-12T18:15:38.239Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04150900-2025-02-28 2026-05-12T18:16:11.145Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04475939-2025-02-26 2026-05-12T18:18:14.792Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03805594-2025-02-25 2026-05-12T18:18:40.805Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05166577-2025-02-24 2026-05-12T18:18:54.694Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03829319-2025-02-21 2026-05-12T18:19:21.211Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03221426-2025-02-20 2026-05-12T18:21:59.670Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04882241-2025-02-20 2026-05-12T18:22:54.209Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02907099-2025-02-19 2026-05-12T18:23:46.478Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03222856-2025-02-19 2026-05-12T18:23:58.898Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04875195-2025-02-10 2026-05-12T18:26:38.576Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct02733159-2025-02-10 2026-05-12T18:28:04.431Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03976323-2025-02-06 2026-05-12T18:30:07.591Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2025-01-28 2026-06-12T06:53:33.737Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-12-11 2026-06-12T15:59:57.162Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-09-17 2026-06-12T16:02:41.231Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct05064059-2024-08-15 2026-06-12T16:03:52.438Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-08-07 2026-06-12T16:05:00.112Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-06-17 2026-06-12T16:06:45.786Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-06-07 2026-06-12T16:06:59.105Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03390504-2024-04-15 2026-06-12T16:10:30.528Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-01-25 2026-06-12T16:13:37.538Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2024-01-12 2026-06-12T16:14:05.533Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-12-15 2026-06-12T16:19:28.803Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-11-16 2026-06-12T16:19:45.165Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-11-07 2026-06-12T16:20:21.031Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-10-31 2026-06-12T16:20:33.796Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-10-23 2026-06-12T16:21:03.541Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-10-16 2026-06-12T16:21:25.491Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-10-12 2026-06-12T16:21:56.980Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct02506153-2023-09-15 2026-06-12T16:22:36.776Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-08-14 2026-06-12T16:23:10.105Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct04223856-2023-08-08 2026-06-12T16:24:07.220Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-04-03 2026-06-12T16:26:59.021Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-03-28 2026-06-12T16:27:13.097Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2023-01-26 2026-06-12T16:27:47.832Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2022-12-16 2026-06-12T16:31:20.615Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2022-05-20 2026-06-12T16:33:47.922Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2022-03-21 2026-06-12T16:35:23.267Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2022-02-04 2026-06-12T16:36:33.840Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-12-17 2026-06-12T16:43:37.405Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-12-03 2026-06-12T16:43:51.681Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-11-17 2026-06-12T16:44:11.048Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-10-13 2026-06-12T16:45:15.338Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-08-31 2026-06-12T16:45:42.838Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-08-10 2026-06-12T16:46:17.782Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-07-26 2026-06-12T16:46:35.547Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-07-21 2026-06-12T16:46:59.251Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-07-01 2026-06-12T16:47:28.600Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-05-05 2026-06-12T16:48:28.657Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-03-22 2026-06-12T16:49:19.743Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2021-03-16 2026-06-12T16:49:34.501Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-11-13 2026-06-12T16:55:05.966Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-10-14 2026-06-12T16:55:20.656Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-10-02 2026-06-12T16:55:53.099Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-06-29 2026-06-12T16:57:25.441Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-06-24 2026-06-12T16:57:44.412Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-06-16 2026-06-12T16:58:09.733Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-04-28 2026-06-12T16:59:46.209Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2020-01-08 2026-06-12T17:00:42.647Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-09-17 2026-06-12T17:05:40.084Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-07-30 2026-06-12T17:05:52.023Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-06-17 2026-06-12T17:06:27.520Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-06-10 2026-06-12T17:06:42.589Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-04-19 2026-06-12T17:07:19.683Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-04-11 2026-06-12T17:07:51.709Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2019-02-15 2026-06-12T17:09:52.248Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-12-28 2026-06-12T17:13:06.900Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-12-19 2026-06-12T17:13:19.581Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-11-09 2026-06-12T17:13:53.641Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-10-30 2026-06-12T17:14:06.033Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/phase-3-primary-completion-nct03260894-2018-08-22 2026-06-12T17:14:32.642Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-08-20 2026-06-12T17:14:49.336Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-08-16 2026-06-12T17:15:24.959Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-06-19 2026-06-12T17:16:10.076Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-06-13 2026-06-12T17:16:57.791Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2018-06-12 2026-06-12T17:17:15.100Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-09-22 2026-06-12T17:22:20.154Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-05-23 2026-06-12T17:23:35.822Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-05-18 2026-06-12T17:23:56.188Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-05-17 2026-06-12T17:24:14.268Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-05-10 2026-06-12T17:24:30.753Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2017-03-14 2026-06-12T17:25:15.301Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2016-10-24 2026-06-12T17:28:17.919Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2016-08-05 2026-06-12T17:29:10.160Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2015-12-18 2026-06-12T17:32:12.925Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-supplemental-application-keytruda-pembrolizumab-2015-10-02 2026-06-12T17:32:52.620Z monthly 0.65 https://hipa.ai/drug/pembrolizumab/updates/fda-approved-keytruda-pembrolizumab-bla-125514-2014-09-04 2026-06-12T17:35:48.424Z monthly 0.65 https://hipa.ai/drug/plozasiran/updates/trial-results-posted-nct05902598-2026-02-27 2026-05-12T17:49:01.001Z monthly 0.65 https://hipa.ai/drug/plozasiran/updates/trial-results-posted-nct05089084-2026-02-04 2026-05-12T17:38:18.257Z monthly 0.65 https://hipa.ai/drug/plozasiran/updates/fda-approved-redemplo-plozasiran-nda-219947-2025-11-18 2026-05-11T06:17:40.044Z monthly 0.65 https://hipa.ai/drug/plozasiran/updates/phase-3-primary-completion-nct05089084-2024-04-29 2026-06-12T16:08:41.584Z monthly 0.65 https://hipa.ai/drug/ponsegromab/updates/trial-results-posted-nct05492500-2026-03-18 2026-05-19T21:58:44.903Z monthly 0.65 https://hipa.ai/drug/ponsegromab/updates/trial-results-posted-nct05546476-2025-04-29 2026-05-12T17:38:22.078Z monthly 0.65 https://hipa.ai/drug/prasinezumab/updates/trial-results-posted-nct04777331-2025-12-02 2026-05-12T17:38:19.058Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/boxed-warning-present-label-estradiol-norethindrone-acetate-2026-05-29 2026-06-12T06:11:27.563Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/trial-results-posted-nct04756037-2026-05-13 2026-06-12T06:25:59.732Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/phase-3-primary-completion-nct06439524-2026-02-15 2026-05-19T23:06:14.241Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/boxed-warning-present-label-hailey-1-5-30-label-effective-2026-01-29 2026-05-11T05:23:04.577Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/trial-results-posted-nct06462014-2025-12-11 2026-05-19T23:07:07.014Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/boxed-warning-present-label-estradiol-label-effective-2025-2025-11-25 2026-05-11T06:09:16.135Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/boxed-warning-present-label-microgestin-1-20-label-effective-2025-11-12 2026-05-11T06:21:58.607Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/indication-usage-updated-orgovyx-label-effective-2025-10-10-2025-10-10 2026-05-11T06:48:05.978Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/trial-results-posted-nct05320406-2025-09-22 2026-05-12T17:38:19.957Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/trial-results-posted-nct04527003-2025-04-04 2026-05-12T17:38:22.507Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/phase-3-primary-completion-nct04756037-2025-02-25 2026-06-12T06:52:47.588Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/phase-3-primary-completion-nct04756037-2025-02-18 2026-05-12T18:24:08.216Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/once-daily-oral-relugolix-combination-therapy-versus-placebo-2022-01-01 2026-06-12T16:36:58.215Z monthly 0.65 https://hipa.ai/drug/relugolix/updates/oral-relugolix-androgen-deprivation-therapy-advanced-2020-01-01 2026-06-12T17:02:34.572Z monthly 0.65 https://hipa.ai/drug/remternetug/updates/phase-3-primary-completion-nct05463731-2024-04-24 2026-06-12T16:09:08.137Z monthly 0.65 https://hipa.ai/drug/repotrectinib/updates/phase-3-primary-completion-nct06140836-2026-03-13 2026-05-12T17:48:21.711Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct05929066-2026-04-30 2026-05-12T17:38:17.220Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct05882045-2026-04-30 2026-05-12T17:38:17.257Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct05882045-2026-04-16 2026-06-12T06:32:05.601Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct05929066-2026-04-06 2026-06-12T06:48:08.299Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct06354660-2026-01-22 2026-05-12T17:38:18.432Z monthly 0.65 https://hipa.ai/drug/retatrutide/updates/phase-3-primary-completion-nct05931367-2025-11-14 2026-05-19T22:35:48.837Z monthly 0.65 https://hipa.ai/drug/revumenib/updates/fda-approved-supplemental-application-revuforj-revumenib-2025-10-24 2026-05-12T18:00:52.465Z monthly 0.65 https://hipa.ai/drug/rgn-259/updates/phase-3-primary-completion-nct05555589-2026-04-30 2026-05-12T17:42:57.451Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/indication-usage-updated-nurtec-odt-label-effective-2026-06-2026-06-04 2026-06-12T06:05:37.003Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct06221111-2026-05-22 2026-06-12T06:20:29.608Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05518123-2026-05-22 2026-06-12T06:40:45.770Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05509400-2026-04-21 2026-05-19T22:00:02.912Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct06680206-2026-01-22 2026-05-19T23:12:41.454Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05217927-2025-12-16 2026-05-19T21:32:55.095Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05207865-2025-09-03 2026-05-19T21:31:41.918Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/phase-3-primary-completion-nct05810038-2025-08-25 2026-05-19T22:24:26.865Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct04629950-2025-07-17 2026-05-19T20:48:55.145Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05399485-2025-07-14 2026-05-19T21:49:31.457Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05248997-2025-03-26 2026-05-12T17:38:22.739Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05371652-2025-02-20 2026-05-12T18:21:34.046Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/trial-results-posted-nct05399459-2025-02-10 2026-05-12T18:27:45.895Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/fda-approved-supplemental-application-nurtec-odt-rimegepant-2022-04-11 2026-06-12T16:34:36.768Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/fda-approved-supplemental-application-nurtec-odt-rimegepant-2021-05-27 2026-06-12T16:47:48.359Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/oral-rimegepant-preventive-treatment-migraine-phase-2-3-2021-01-01 2026-06-12T16:52:36.541Z monthly 0.65 https://hipa.ai/drug/rimegepant/updates/fda-approved-nurtec-odt-rimegepant-sulfate-nda-212728-2020-02-27 2026-06-12T17:00:25.907Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/fda-approved-supplemental-application-skyrizi-risankizumab-2026-03-06 2026-05-11T04:57:00.274Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/trial-results-posted-nct05969223-2026-02-24 2026-05-12T17:50:08.838Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/trial-results-posted-nct05283135-2025-10-24 2026-05-19T21:37:35.820Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/fda-approved-supplemental-application-skyrizi-risankizumab-2025-09-03 2026-05-12T18:03:29.222Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/fda-approved-supplemental-application-skyrizi-risankizumab-2025-09-03-139352 2026-05-12T17:01:29.477Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/trial-results-posted-nct04435600-2025-05-20 2026-05-19T20:32:58.380Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/risankizumab-ulcerative-colitis-two-randomized-clinical-2024-01-01 2026-06-12T16:15:20.930Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/risankizumab-versus-ustekinumab-moderate-severe-crohn-s-2024-01-01 2026-06-12T16:17:19.618Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/risankizumab-maintenance-therapy-moderately-severely-active-2022-01-01 2026-06-12T16:36:46.012Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/risankizumab-induction-therapy-crohn-s-disease-results-phase-2022-01-01 2026-06-12T16:40:21.870Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/risankizumab-compared-adalimumab-patients-moderate-severe-2019-01-01 2026-06-12T17:10:06.876Z monthly 0.65 https://hipa.ai/drug/risankizumab/updates/efficacy-safety-risankizumab-moderate-severe-plaque-2018-01-01 2026-06-12T17:21:28.553Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct03440736-2026-04-22 2026-05-12T17:38:17.502Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/fda-approved-supplemental-application-cosentyx-secukinumab-2026-04-17 2026-05-09T18:54:18.869Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/fda-approved-supplemental-application-cosentyx-secukinumab-2026-04-17-76dee5 2026-05-12T17:01:29.527Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/fda-approved-supplemental-application-cosentyx-secukinumab-2026-03-12 2026-05-11T04:53:34.947Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct05380453-2026-02-24 2026-05-12T17:38:18.024Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct06630559-2026-02-18 2026-05-19T23:12:21.302Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct04732117-2026-01-30 2026-05-12T17:38:18.328Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct05758415-2025-12-18 2026-05-12T17:38:18.737Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct05569174-2025-12-02 2026-05-12T17:38:19.048Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct05722522-2025-12-02 2026-05-12T17:38:19.065Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct04632927-2025-10-16 2026-05-19T20:48:55.674Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct05767034-2025-09-10 2026-05-12T17:38:20.186Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct06398652-2025-06-30 2026-05-19T23:02:56.048Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct04717466-2025-06-05 2026-05-19T20:53:25.462Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/trial-results-posted-nct03769168-2025-05-23 2026-05-12T17:38:21.566Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct06110676-2025-04-30 2026-05-12T17:38:21.972Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/phase-3-primary-completion-nct04930094-2025-04-11 2026-05-12T17:38:22.306Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/bimekizumab-versus-secukinumab-plaque-psoriasis-n-engl-j-med-2021-01-01 2026-06-12T16:52:09.746Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/secukinumab-versus-adalimumab-treatment-active-psoriatic-2020-01-01 2026-06-12T17:04:01.169Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/guselkumab-versus-secukinumab-treatment-moderate-severe-2019-01-01 2026-06-12T17:11:46.576Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/secukinumab-inhibition-interleukin-17a-patients-psoriatic-2015-01-01 2026-06-12T17:33:35.854Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/secukinumab-human-anti-interleukin-17a-monoclonal-antibody-2015-01-01 2026-06-12T17:33:59.601Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/secukinumab-interleukin-17a-inhibitor-ankylosing-spondylitis-2015-01-01 2026-06-12T17:35:08.593Z monthly 0.65 https://hipa.ai/drug/secukinumab/updates/secukinumab-plaque-psoriasis-results-two-phase-3-trials-n-2014-01-01 2026-06-12T17:36:01.215Z monthly 0.65 https://hipa.ai/drug/seltorexant/updates/trial-results-posted-nct04533529-2026-05-12 2026-06-12T06:28:14.497Z monthly 0.65 https://hipa.ai/drug/seltorexant/updates/trial-results-posted-nct04532749-2025-06-04 2026-05-19T20:41:07.995Z monthly 0.65 https://hipa.ai/drug/seltorexant/updates/phase-3-primary-completion-nct04533529-2023-04-25 2026-06-12T16:26:46.348Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05813912-2026-06-03 2026-06-12T06:07:29.850Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/boxed-warning-present-label-ozempic-label-effective-2026-05-2026-05-19 2026-06-12T06:43:56.201Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct06041217-2026-05-18 2026-06-12T06:45:51.019Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05514535-2026-05-11 2026-05-19T22:00:55.398Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05035095-2026-05-07 2026-05-12T17:38:16.577Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct07036172-2026-04-30 2026-05-12T17:38:17.111Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05649137-2026-04-27 2026-05-12T17:38:17.307Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05646706-2026-04-23 2026-05-12T17:38:17.353Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05144984-2026-04-09 2026-05-19T21:26:20.091Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct05586802-2026-04-01 2026-05-12T17:38:17.682Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06716216-2026-03-20 2026-05-12T17:38:17.781Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/fda-approved-supplemental-application-wegovy-semaglutide-2026-03-19 2026-05-11T04:50:36.223Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05564117-2026-02-25 2026-05-19T22:05:59.379Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05891496-2026-02-24 2026-05-19T22:31:31.824Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04019197-2026-02-17 2026-05-19T20:00:30.204Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04779697-2026-02-10 2026-05-19T20:56:45.069Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05788965-2026-01-21 2026-05-12T17:38:18.433Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04865770-2026-01-14 2026-05-19T21:01:34.486Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04969939-2026-01-08 2026-05-19T21:10:16.630Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/efficacy-safety-once-daily-oral-orforglipron-compared-oral-2026-01-01 2026-05-12T17:36:29.983Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/efficacy-safety-oral-semaglutide-14-mg-flexible-dose-early-2026-01-01 2026-05-12T17:37:38.833Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/fda-approved-wegovy-semaglutide-nda-218316-2025-12-22 2026-05-11T05:46:17.183Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05822830-2025-11-26 2026-05-19T22:25:35.239Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04971785-2025-11-26 2026-05-19T21:10:43.340Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct03919929-2025-11-25 2026-05-12T17:38:19.161Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/fda-approved-supplemental-application-wegovy-semaglutide-2025-11-21 2026-05-11T06:12:42.304Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05768945-2025-11-10 2026-05-12T17:59:16.770Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/fda-approved-supplemental-application-ozempic-oral-2025-10-17 2026-05-11T06:40:10.944Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct05726227-2025-10-15 2026-05-19T22:19:29.724Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct03914326-2025-09-22 2026-05-19T19:53:08.939Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct04777396-2025-09-16 2026-05-12T17:38:20.069Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct04777409-2025-09-15 2026-05-12T17:38:20.113Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04126603-2025-09-09 2026-05-19T20:08:15.035Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06339086-2025-08-30 2026-05-19T23:01:37.498Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06604624-2025-08-27 2026-05-12T17:38:20.371Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/fda-approved-supplemental-application-wegovy-semaglutide-2025-08-15 2026-05-11T07:25:08.485Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05537233-2025-08-12 2026-05-19T22:02:10.044Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05530577-2025-07-18 2026-05-12T17:38:20.920Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05616013-2025-07-18 2026-05-19T22:10:21.736Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04560998-2025-07-08 2026-05-19T20:43:34.713Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06161844-2025-05-14 2026-05-12T17:38:21.719Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05786521-2025-05-04 2026-05-12T17:38:21.901Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct04596631-2025-04-29 2026-05-12T17:38:21.975Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05302596-2025-04-17 2026-05-12T17:38:22.205Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct05813912-2025-04-14 2026-06-12T06:51:55.230Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct04998136-2025-04-03 2026-05-12T17:38:22.508Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06041217-2025-04-02 2026-05-12T17:38:22.604Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct05073835-2025-03-31 2026-05-12T17:38:22.630Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05520775-2025-03-24 2026-05-12T17:38:22.769Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct03819153-2025-03-20 2026-05-12T17:38:22.798Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct05514535-2025-03-05 2026-05-12T17:38:23.059Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct06616961-2025-02-28 2026-05-12T17:38:23.114Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05533632-2025-02-10 2026-05-12T18:27:19.784Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/oral-semaglutide-dose-25-mg-adults-overweight-obesity-n-engl-2025-01-01 2026-06-12T06:56:11.789Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/semaglutide-walking-capacity-people-symptomatic-peripheral-2025-01-01 2026-06-12T15:52:29.562Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-trial-semaglutide-metabolic-dysfunction-associated-2025-01-01 2026-06-12T15:54:30.794Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/cagrilintide-semaglutide-adults-overweight-obesity-type-2-2025-01-01 2026-06-12T15:55:38.311Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/oral-semaglutide-cardiovascular-outcomes-high-risk-type-2-2025-01-01 2026-06-12T15:56:36.487Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/semaglutide-cardiovascular-outcomes-baseline-changes-2025-01-01 2026-06-12T15:58:11.052Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/coadministered-cagrilintide-semaglutide-adults-overweight-2025-01-01 2026-06-12T15:58:25.992Z monthly 0.65 https://hipa.ai/drug/semaglutide/updates/phase-3-primary-completion-nct04560998-2024-06-05 2026-06-12T16:07:21.262Z monthly 0.65 https://hipa.ai/drug/sigvotatug-vedotin/updates/phase-3-primary-completion-nct06012435-2026-05-18 2026-06-12T06:44:36.867Z monthly 0.65 https://hipa.ai/drug/sigvotatug-vedotin/updates/phase-3-primary-completion-nct06012435-2026-03-12 2026-05-12T17:38:17.913Z monthly 0.65 https://hipa.ai/drug/sotorasib/updates/trial-results-posted-nct05054725-2026-01-06 2026-05-19T21:17:46.339Z monthly 0.65 https://hipa.ai/drug/sotorasib/updates/trial-results-posted-nct05313009-2025-12-16 2026-05-19T21:40:24.070Z monthly 0.65 https://hipa.ai/drug/sotorasib/updates/phase-3-primary-completion-nct05198934-2025-07-16 2026-05-12T17:38:20.955Z monthly 0.65 https://hipa.ai/drug/sotorasib/updates/trial-results-posted-nct05374538-2025-05-01 2026-05-12T17:38:21.917Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/fda-approved-supplemental-application-filspari-sparsentan-2026-04-13 2026-05-09T18:57:51.042Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/trial-results-posted-nct05856760-2025-11-20 2026-05-12T17:38:19.213Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/fda-approved-supplemental-application-filspari-sparsentan-2025-08-27 2026-05-11T07:17:41.545Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/sparsentan-versus-irbesartan-focal-segmental-2024-01-01 2026-06-12T16:19:03.679Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/sparsentan-patients-iga-nephropathy-prespecified-interim-2023-01-01 2026-06-12T16:30:01.161Z monthly 0.65 https://hipa.ai/drug/sparsentan/updates/efficacy-safety-sparsentan-versus-irbesartan-patients-iga-2023-01-01 2026-06-12T16:31:02.292Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06077864-2026-05-08 2026-06-12T06:30:51.019Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06077864-2026-05-01 2026-05-12T17:38:17.007Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06066528-2025-12-12 2026-05-19T22:46:42.838Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06176365-2025-12-03 2026-05-19T22:54:58.532Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06066515-2025-12-02 2026-05-19T22:46:42.379Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06309992-2025-10-09 2026-05-19T23:00:55.521Z monthly 0.65 https://hipa.ai/drug/survodutide/updates/phase-3-primary-completion-nct06214741-2025-07-29 2026-05-19T22:57:16.468Z monthly 0.65 https://hipa.ai/drug/talquetamab/updates/phase-3-primary-completion-nct06208150-2026-04-23 2026-05-19T22:56:30.000Z monthly 0.65 https://hipa.ai/drug/talquetamab/updates/phase-3-primary-completion-nct06208150-2026-04-01 2026-06-12T06:48:32.474Z monthly 0.65 https://hipa.ai/drug/talquetamab/updates/fda-approved-talvey-talquetamab-bla-761342-2023-08-09 2026-06-12T16:23:52.380Z monthly 0.65 https://hipa.ai/drug/tarlatamab/updates/trial-results-posted-nct06502977-2026-04-15 2026-05-12T17:38:17.587Z monthly 0.65 https://hipa.ai/drug/tarlatamab/updates/fda-approved-supplemental-application-imdelltra-amg757-2025-11-19 2026-05-11T06:13:45.476Z monthly 0.65 https://hipa.ai/drug/tarlatamab/updates/trial-results-posted-nct04702737-2025-09-12 2026-05-12T17:38:20.136Z monthly 0.65 https://hipa.ai/drug/teclistamab/updates/fda-approved-supplemental-application-tecvayli-teclistamab-2026-03-05 2026-05-11T04:58:51.474Z monthly 0.65 https://hipa.ai/drug/teclistamab/updates/phase-3-primary-completion-nct05572515-2025-10-13 2026-05-12T17:38:19.777Z monthly 0.65 https://hipa.ai/drug/teclistamab/updates/fda-approved-supplemental-application-tecvayli-teclistamab-2024-11-22 2026-06-12T16:00:17.657Z monthly 0.65 https://hipa.ai/drug/teclistamab/updates/fda-approved-supplemental-application-tecvayli-teclistamab-2024-02-20 2026-06-12T16:12:13.935Z monthly 0.65 https://hipa.ai/drug/teclistamab/updates/fda-approved-tecvayli-teclistamab-cqyv-bla-761291-2022-10-25 2026-06-12T16:32:18.145Z monthly 0.65 https://hipa.ai/drug/telisotuzumab-vedotin/updates/trial-results-posted-nct05513703-2025-10-24 2026-05-12T17:38:19.571Z monthly 0.65 https://hipa.ai/drug/telisotuzumab-vedotin/updates/fda-approved-emrelis-telisotuzumab-vedotin-bla-761384-2025-05-14 2026-05-11T08:27:28.728Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/phase-3-primary-completion-nct06047548-2026-01-20 2026-05-19T22:45:24.809Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/fda-approved-supplemental-application-mounjaro-tirzepatide-2025-12-19 2026-05-11T05:46:59.268Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05963022-2025-10-21 2026-05-19T22:37:16.945Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05260021-2025-09-26 2026-05-19T21:35:13.233Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05696847-2025-08-26 2026-05-19T22:16:50.665Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct04847557-2025-08-20 2026-05-19T21:00:24.436Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05691712-2025-08-08 2026-05-12T17:38:20.642Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05412004-2025-04-30 2026-05-12T17:38:21.973Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/trial-results-posted-nct05978713-2025-04-27 2026-05-12T17:38:22.079Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-heart-failure-preserved-ejection-fraction-2025-01-01 2026-06-12T15:52:14.296Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-compared-semaglutide-treatment-obesity-n-engl-j-2025-01-01 2026-06-12T15:54:57.561Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/efficacy-safety-tirzepatide-children-adolescents-type-2-2025-01-01 2026-06-12T15:55:53.406Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-obesity-treatment-diabetes-prevention-n-engl-j-2025-01-01 2026-06-12T15:56:50.678Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/cardiovascular-outcomes-tirzepatide-versus-dulaglutide-type-2025-01-01 2026-06-12T15:57:44.509Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-weight-reduction-chinese-adults-obesity-surmount-2024-01-01 2026-06-12T16:18:06.423Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/continued-treatment-tirzepatide-maintenance-weight-reduction-2024-01-01 2026-06-12T16:18:18.331Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-treatment-obstructive-sleep-apnea-obesity-n-engl-2024-01-01 2026-06-12T16:16:33.466Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-vs-insulin-lispro-added-basal-insulin-type-2-2023-01-01 2026-06-12T16:28:05.730Z monthly 0.65 https://hipa.ai/drug/tirzepatide/updates/tirzepatide-once-weekly-treatment-obesity-people-type-2-2023-01-01 2026-06-12T16:29:01.138Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-09 2026-06-12T05:58:06.793Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-08 2026-06-12T06:01:05.265Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-05 2026-06-12T06:02:57.603Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-04 2026-06-12T06:03:45.772Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-02 2026-06-12T06:08:42.119Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-05-31 2026-06-12T06:09:25.817Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct01500551-2026-03-23 2026-05-12T17:38:17.780Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-xr-tofacitinib-2026-03-06 2026-05-11T04:57:28.893Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-tofacitinib-2026-03-06 2026-05-11T04:57:39.859Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-tofacitinib-2026-03-06-0f5b72 2026-05-12T17:01:29.620Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/phase-3-primary-completion-nct06020144-2026-01-15 2026-06-12T06:49:32.854Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct04496960-2025-12-18 2026-05-12T17:38:18.756Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct04246372-2025-12-11 2026-05-19T20:17:40.854Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-tofacitinib-2025-10-16 2026-05-11T16:07:52.014Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-tofacitinib-2025-10-16-d43adb 2026-05-12T17:01:29.576Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/phase-3-primary-completion-nct06172361-2025-09-30 2026-05-12T17:38:19.905Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct06474078-2025-09-16 2026-05-12T17:38:20.069Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct06418529-2025-07-31 2026-05-19T23:04:23.086Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/phase-3-primary-completion-nct05749666-2025-07-20 2026-05-12T17:38:20.899Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/phase-3-primary-completion-nct05326464-2025-06-16 2026-05-19T21:40:54.166Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct03000439-2025-06-03 2026-05-12T17:38:21.437Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct06202560-2025-05-30 2026-05-12T17:38:21.516Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct04415151-2025-03-28 2026-05-12T17:38:22.718Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/trial-results-posted-nct05048238-2025-03-21 2026-05-12T17:38:22.769Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/phase-3-primary-completion-nct06020144-2025-02-28 2026-05-12T17:38:23.115Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-tofacitinib-2025-02-21 2026-05-12T18:19:37.859Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/fda-approved-supplemental-application-xeljanz-xr-tofacitinib-2025-02-21 2026-05-12T18:19:50.794Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/tofacitinib-juvenile-idiopathic-arthritis-double-blind-2022-01-01 2026-06-12T16:39:26.077Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/effect-tocilizumab-disease-activity-patients-active-2022-01-01 2026-06-12T16:40:09.596Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/tofacitinib-patients-hospitalized-covid-19-pneumonia-n-engl-2021-01-01 2026-06-12T16:54:20.094Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/tofacitinib-induction-maintenance-therapy-ulcerative-colitis-2017-01-01 2026-06-12T17:25:47.260Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/tofacitinib-adalimumab-versus-placebo-psoriatic-arthritis-n-2017-01-01 2026-06-12T17:26:20.621Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/tofacitinib-psoriatic-arthritis-patients-inadequate-response-2017-01-01 2026-06-12T17:26:35.131Z monthly 0.65 https://hipa.ai/drug/tofacitinib/updates/rituximab-versus-cyclophosphamide-anca-associated-vasculitis-2010-01-01 2026-06-12T17:37:48.670Z monthly 0.65 https://hipa.ai/drug/tolebrutinib/updates/phase-3-primary-completion-nct04458051-2025-11-14 2026-05-19T20:33:47.073Z monthly 0.65 https://hipa.ai/drug/tolebrutinib/updates/trial-results-posted-nct03996291-2025-10-23 2026-05-12T17:38:19.572Z monthly 0.65 https://hipa.ai/drug/tolebrutinib/updates/trial-results-posted-nct04410991-2025-06-18 2026-05-12T17:38:21.238Z monthly 0.65 https://hipa.ai/drug/tolebrutinib/updates/trial-results-posted-nct04410978-2025-06-18 2026-05-12T17:38:21.243Z monthly 0.65 https://hipa.ai/drug/tolebrutinib/updates/trial-results-posted-nct04411641-2025-06-18 2026-05-12T17:38:21.243Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct05113251-2026-06-09 2026-06-12T05:58:29.687Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2026-05-15 2026-06-12T06:46:32.814Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2026-04-27 2026-06-12T06:31:17.338Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct05744375-2026-03-12 2026-05-19T22:20:35.008Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct03742102-2026-02-02 2026-05-12T17:52:12.483Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/phase-3-primary-completion-nct06585969-2026-01-01 2026-05-19T23:11:51.324Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2025-12-15 2026-05-11T05:54:01.200Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct03334617-2025-10-27 2026-05-19T19:24:09.839Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct04539938-2025-07-31 2026-05-12T17:38:20.752Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct04420598-2025-06-24 2026-05-19T20:31:32.232Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct04739761-2025-05-16 2026-05-12T17:38:21.668Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct04494425-2025-04-02 2026-05-12T17:38:22.629Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/phase-3-primary-completion-nct05113251-2025-03-12 2026-05-12T18:13:49.685Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2025-01-27 2026-06-12T06:53:49.016Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2024-04-05 2026-06-12T16:11:03.650Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2024-02-15 2026-06-12T16:12:29.125Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/phase-3-primary-completion-nct04739761-2024-02-08 2026-06-12T16:12:57.050Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2022-11-04 2026-06-12T16:32:00.674Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2022-08-11 2026-06-12T16:32:32.364Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2022-08-05 2026-06-12T16:32:47.582Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2022-05-04 2026-06-12T16:34:21.318Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-supplemental-application-enhertu-fam-2021-01-15 2026-06-12T16:51:12.517Z monthly 0.65 https://hipa.ai/drug/trastuzumab-deruxtecan/updates/fda-approved-enhertu-fam-trastuzumab-deruxtecan-nxki-bla-2019-12-20 2026-06-12T17:04:47.988Z monthly 0.65 https://hipa.ai/drug/ubrogepant/updates/ubrogepant-treatment-migraine-attacks-during-prodrome-phase-2023-01-01 2026-06-12T16:29:46.460Z monthly 0.65 https://hipa.ai/drug/ubrogepant/updates/ubrogepant-treatment-migraine-n-engl-j-med-2019-01-01 2026-06-12T17:10:58.555Z monthly 0.65 https://hipa.ai/drug/ubrogepant/updates/effect-ubrogepant-vs-placebo-pain-most-bothersome-associated-2019-01-01 2026-06-12T17:12:13.085Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/phase-3-primary-completion-nct06390722-2026-01-05 2026-05-19T23:02:39.893Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/fda-approved-supplemental-application-rinvoq-upadacitinib-2025-10-10 2026-05-11T06:47:24.734Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/phase-3-primary-completion-nct06118411-2025-09-23 2026-05-19T22:51:28.143Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/trial-results-posted-nct05507580-2025-07-29 2026-05-19T22:00:02.452Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/fda-approved-supplemental-application-rinvoq-upadacitinib-2025-04-28 2026-05-11T08:38:41.403Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/trial-results-posted-nct03725202-2025-03-07 2026-05-12T17:38:23.013Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/trial-results-posted-nct05601882-2025-02-14 2026-05-12T18:25:15.011Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/phase-3-trial-upadacitinib-giant-cell-arteritis-n-engl-j-med-2025-01-01 2026-06-12T15:58:51.689Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/fda-approved-rinvoq-upadacitinib-nda-218347-2024-04-26 2026-06-12T16:08:55.572Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/upadacitinib-treatment-active-non-radiographic-axial-2022-01-01 2026-06-12T16:41:22.041Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/phase-3-primary-completion-nct03607422-2021-03-11 2026-06-12T16:50:00.617Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/trial-upadacitinib-adalimumab-psoriatic-arthritis-n-engl-j-2021-01-01 2026-06-12T16:51:31.578Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/once-daily-upadacitinib-versus-placebo-adolescents-adults-2021-01-01 2026-06-12T16:53:51.295Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/safety-efficacy-upadacitinib-combination-topical-2021-01-01 2026-06-12T16:54:37.259Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/trial-upadacitinib-abatacept-rheumatoid-arthritis-n-engl-j-2020-01-01 2026-06-12T17:04:31.446Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/upadacitinib-monotherapy-patients-active-rheumatoid-2019-01-01 2026-06-12T17:12:49.014Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/safety-efficacy-upadacitinib-patients-active-rheumatoid-2018-01-01 2026-06-12T17:19:53.492Z monthly 0.65 https://hipa.ai/drug/upadacitinib/updates/safety-efficacy-upadacitinib-patients-rheumatoid-arthritis-2018-01-01 2026-06-12T17:20:28.840Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/trial-results-posted-nct05306873-2025-09-09 2026-05-19T21:39:27.907Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/phase-3-primary-completion-nct05962788-2025-07-04 2026-05-12T17:38:21.028Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/phase-3-primary-completion-nct05288855-2025-07-03 2026-05-12T17:38:21.089Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/efficacy-safety-voclosporin-versus-placebo-lupus-nephritis-2022-01-01 2026-06-12T16:37:13.624Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/mycophenolate-versus-azathioprine-maintenance-therapy-lupus-2011-01-01 2026-06-12T17:37:32.264Z monthly 0.65 https://hipa.ai/drug/voclosporin/updates/efficacy-isa247-plaque-psoriasis-randomised-multicentre-2008-01-01 2026-06-12T17:38:27.691Z monthly 0.65 https://hipa.ai/drug/zilebesiran/updates/trial-results-posted-nct06423352-2026-04-30 2026-05-12T17:38:17.086Z monthly 0.65 https://hipa.ai/drug/zilebesiran/updates/trial-results-posted-nct05103332-2025-07-09 2026-05-19T21:21:11.756Z monthly 0.65 https://hipa.ai/drug/zolbetuximab/updates/fda-approved-supplemental-application-vyloy-zolbetuximab-2025-06-06 2026-05-11T08:08:48.189Z monthly 0.65 https://hipa.ai/drug/zolbetuximab/updates/trial-results-posted-nct03504397-2025-02-26 2026-05-12T18:17:55.440Z monthly 0.65